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To my family
Some are influenced by the love o f wealth 
while others are blindly led on the mad fever fo r  
power and domination, but the finest type o f man gives 
himself up to discovering the meaning and purpose o f life itself 
He seeks to uncover the secrets o f nature. 
This is the man I  call philosopher...
Pythagoras
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ABBREVATIONS
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ATP adenosine triphosphate
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INTRODUCTION
Ischaemia occurs clinically with loss o f arterial flow to an end-organ as seen 
when an embolus travels, e.g. to the brain, the intestine or the lower extremities. 
This knowledge is already over 150 years old since Dr. Rudolf Ludwing Karl 
Virchow described the phenomena that he called “embolism” and “thrombosis”; 
since then the understanding of stroke and as well as of the origin of ischaemia 
has changed (Safavi-Abbasi, Reis et al. 2006).
Despite the long period of time, the issue of ischaemia and restoration of 
blood flow after ischaemia, i.e. reperfusion, are still addressed within important 
research fields. Especially during the last three decades, vascular surgeons and 
scientists have been deeply involved, both in clinical work and in basic 
research, with the phenomenon of ischaemia/reperfusion (I/R) injury (IRI). 
They are intensively seeking the knowledge and explanation of IRI and its 
harmful distal-organ consequences. Every vascular surgeon understands that an 
episode of clamping during different vascular reconstructive operations is 
unavoidable, which induces ischaemia and reperfusion event. Such clamping 
situations are inevitable during ruptured or elective abdominal aortic repair and 
during carotid artery endarterectomy.
Further, high-grade (severe) oxidative stress (OxS) due to ischaemia, fol­
lowed by reperfusion, cause significant skeletal or brain damage and dys­
function (Karapanayiotides, Meuli et al. 2005), (Pattwell, McArdle et al. 2001). 
It is widely accepted that although OxS play a major role in the pathological 
cascade of I/R injury (Lee, Zipfel et al. 1999), (Lindsay, Walker et al. 1988), the 
phenomenon of OxS does not yet cover all aspects of IRI. Regardless of this 
knowledge, recent scientific literature contains innovative information about 
OxS and scientific results about the possibilities of protection against IRI, 
associated with the “glutathione world” (Westman, Johansson et al. 2006), 
(Anderson, Nilsson et al. 2004). Furthermore, some glutathione precursors like 
N-acetylcysteine have actually shown a tendency of protection against IRI of 
the heart, liver and intestine (Koramaz, Pulathan et al. 2006), (Akgun, Caliskan 
et al. 2005), (Caglikulekci, Dirlik et al. 2006), (Weinbroum 2006). Use of 
glutathione analogues is also believed to be a promising tool against IRI and 
high-grade OxS (Anderson, Nilsson et al. 2004), (Yamoto M 1993).
One part of the current PhD thesis deals with the in vitro and in vivo 
investigation of a novel glutathione analogue, named UPF1, using a well-known 
and widely recognised rat model of four-vessel occlusion. Another part addres­
ses the not yet fully elucidated issue of grade of OxS and I/R injury (both in 
cellular and systemic antioxidant systems) during abdominal aortic aneurysm 
resection and carotid artery endarterectomy.
We set the hypothesis of the possible occurrence of cellular or systemic 
high-grade OxS during elective abdominal aortic aneurysm resection and 
carotid artery endarterectomy, which might induce harmful consequences due to
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IRI. We investigated also an original glutathione analogue to diminish t e 
harmful disorders caused by IRI.
We believe that more efforts should be made to study potent protective
agents as glutathione analogues and to simultaneously explore more thoroughly
the mechanisms of IRI using both in vitro and in vivo methods. We hope that
the current PhD thesis contains some “drops” of scientific knowledge feeding
the huge and heterogenic “science sea” and offering some clues in this research 
field.
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REVIEW OF THE LITERATURE
1. Ischaemia/reperfusion injury of the skeletal muscle and 
elective abdominal aortic aneurysm (AAA) repair
Re-establishment of blood flow to previously ischaemic organ/tissues is known 
as reperfusion syndrome (which is itself consisting the term of the ischaemia/ 
reperfusion injury) (Ihnken, Beyersdorf et al. 1995). It should be noted that 
scientific literature contains many synonyms of revascularisation syndrome, 
which are mainly classified according to the cause of acute arterial occlusion, 
e.g. postischaemic syndrome, revascularisation syndrome or Haimovici- 
Lagrain-Comier syndrome, declamping syndrome (directly related to clamping 
and declamping of the aorta), tourniquet syndrome and crush syndrome (caused 
by compression) (Beyersdorf 1991). This list can be supplemented with the 
ischaemia/reperfusion injury (IRI) syndrome of the skeletal muscle.
Reperfusion syndrome was first identified in patients in whom blood flow 
was re-established to ischaemic extremities. Evidently based on literature data, 
the first description of an ischaemic lower limb was published in 1881 by 
Volkmann who found that the ischaemic muscle is related to ischaemic 
contracture following fractures (Von Volkmann 1881). Since then, there have 
been several observations of complications of the ischaemic muscle or of lower 
torso ischaemia. For the first time in 1964, Patman, Poulos and Shires used the 
decompression technique, fasciotomy, in the treatment of ischaemic muscle 
swelling (oedema) (Patman, Poulos et al. 1964). Haimovichi first documented 
the risk of arterial revascularisation of ischaemic extremities in 1960 
(Haimovici 1960). After restoration of blood flow (by embolectomy or/and 
endarterectomy) in an ischaemic limb there may occur, depending of the degree 
of ischaemia, reperfusion syndrome / revascularisation syndrome first named 
“myonephropathic-metabolic syndrome” by Haimovici. He described renal 
failure after the revascularisation of an ischaemic muscle. In 1969 Blaidsell et al 
reviewed the results of revascularisation in patients with ischaemic extremities 
and reported 85% mortality in patients who had paralysis and bluish mottling of 
the lower limb prior to re-establishment of blood flow. Furthermore, they found 
that the reasons for mortality were cardiopulmonary but not mainly renal failure 
as was reported by Haimovici (Stallone, Blaisdell et al. 1969).
The skeletal muscle of the limb is the tissue most vulnerable to ischaemia. 
Because the muscle represents the bulk of the tissue mass in the extremity, 
damage to the muscle is the most critical aspect of limb reperfusion (re­
vascularisation syndrome). In general, the skeletal muscle appears to tolerate 
ischaemia for up to 4—6 h (Blaisdell 2002).
The liability to develop the ischaemia/reperfusion syndrome of ischaemic 
limbs increases mainly with (i) the degree of ischaemia (i.e. complete/ in­
complete), (ii) duration of ischaemia, (iii) volume of the reperfused tissue.
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The degree of ischaemia is the most important single determinant о 
development of the IRI syndrome of the skeletal muscle. Complete ischaemia is 
associated with significantly higher incidence of IRI syndrome compared with 
incomplete ischaemia. Furthermore, acute occlusion of the artery (caused by 
embolus or by clamping during reconstruction vascular operations), without 
collateral circulation, carries higher risk for IRI than clinical situations with 
acute thrombosis where incomplete ischaemia prevails (Dale 1984).
Duration of ischaemia is among the causes of development of the IRI of the 
skeletal muscle. The latter may occur already within 1 hour of acute complete 
occlusion, whereas several hours of incomplete ischaemia may not produce 
local or systemic alterations after reperfusion. According to literature data and 
our experience, the abdominal aortic clamping time is approximately 1 hour, 
which may lead to IRI (Thompson, Nasim et al. 1996).
The volume of the reperfused tissue is of major importance for development 
o f IRI leading to systemic complications and death. The highest mortality rates 
(40-63%) are seen after occlusion of the aorta causing simultaneously ischae­
mia in both lower limbs (Dale 1984), (Littooy and Baker 1986).
It should be emphasised that reperfusion after an ischaemic period in the 
lower limbs always results in some local and systemic alterations. Already as 
early as the 80’s it was noted that the metabolic activity of the skeletal muscle 
of patients undergoing periods of aortic cross-clamping during aorto-iliac 
surgery did not return to normal levels for up to several hours after release of 
the clamp (Eklof, Neglen et al. 1981), (Neglen, Carlsson et al. 1980), (Eklof, 
Neglen et al. 1981), (Neglen, Jabs et al. 1989), (Luo, Hammarqvist et al. 1998).
2. Elective abdominal aortic aneurysm repair and 
ischaemia/reperfusion injury
Even today AAA repair is a substantial challenge for vascular surgeons, espe­
cially ruptured AAA, which result in significant morbidity and mortality. How­
ever, the positive (good) outcome of AAA resection depends on many factors 
including IRI (Murphy, Kolvenbach et al. 1992). During AAA repair, abdominal 
aortic cross clamp application induces lower limb ischaemia/ reperfusion event. 
This situation is unavoidable during aortic surgery. The main problem seems to 
be the duration of the ischaemic event, which may last long enough, with the 
following reperfusion period (after declamping of the aorta), which causes IRI 
affecting tissue/organs (Ar'Rajab, Dawidson et al. 1996; Lindsay, Luo et al. 1999).
During aortic cross clamping, lack of oxygen leads to depletion of the energy 
reserve due to lack of ATP production via aerobic metabolism. Deficiency of 
the metabolic energy requirements in the skeletal muscle tissue causes leakage 
of the membrane, failure in Na-pump function, and cellular excess of sodium 
and calcium, resulting in cell oedema.
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At the same time, excessive production of reactive species (including reac­
tive oxygen species, ROS) occurs, accompanied with elevated degradation of 
ATP as well as other purines, forming more hypoxanthine. Normally, hypo- 
xanthine is oxidized into xanthine by xanthine dehydrogenase, but in ischaemic 
conditions, at elevated cytosolic calcium, xanthine dehydrogenase is converted 
into xanthine oxidase (Schaffer, Roy et al. 1983; Russell, Roth et al. 1989; 
Pang, Forrest et al. 1993). Unlike xanthine dehydrogenase, which uses NAD as 
a substrate, xanthine oxidase uses oxygen. Therefore, restoration of oxygen 
supplementation during reperfusion leads to excessive production of ROS by 
the xanthine/xanthine oxidase system, as well as by mitochondrial electron 
transport chain leakage and by activated neutrophils (Collard and Gelman 
2001). ROS as superoxide, hydroxyl radical, hydrogen peroxide and hypo- 
chloric acid attack the biomembrane of polyunsaturated fatty acids, resulting in 
rapidly elevated lipid peroxidation. Lipid peroxidation of cellular membranes 
leads to a number of harmful alterations, ranging from decreased fluidity to loss 
of selective permeability and signal transduction. Because of the high reactivity 
and short half-life of ROS, their direct quantification is technically very 
complicated. The only technique capable of direct analysis of ROS in vivo is 
electron spin resonance (ESR) spectroscopy, which is used in conjunction with 
appropriate ROS spin trapping (i.e. secondary radical stabilising) chemical 
agent. A number of investigations have described the application of ESR 
spectroscopy for analysis of ROS generated in various animal model systems, 
e.g. canine gracilis muscle model for studying ischaemia/reperfusion pheno­
mena (associated with oxygen free radicals) in the skeletal muscle (Choudhury, 
Sakaguchi et al. 1991). This situation allows the spin trapping agent to be 
introduced via injection or infusion prior to initiation of ROS formation, thereby 
enabling immediate and quantitative complexation of ROS generated with the 
spin trapping agent for subsequent analysis. Use of ESR spectroscopy in 
analysis of ROS in patients is limited since it is not possible to introduce spin 
traps into the human body because of ethical considerations (Brown, Dugdill et 
al. 1998). The ESR procedure cannot be applied in routine clinical work and, 
besides, it is also very costly.
Furthermore, IRI generates high-grade OxS mediated by reactive species and 
leading to several levels of tissue and organ damage. The human body compro­
mises an antioxidant network, including enzymatic (e.g. superoxide dismutase 
and catalase) and nonenzymatic antioxidants (e.g. vitamin E and С and crucial 
cellular antioxidant glutathione), to withstand high grade damage caused by 
OxS. To get a real picture of OxS associated with IRI, it is necessary to assess 
both generalized (systemic) or cellular OxS using an appropriate set of a 
number of biochemical indices as total antioxidative capacity (TAC), 
glutathione content and its redox ratio, indices of lipid peroxidation (diene 
conjugates, DC thiobarbituric acid reactive substances, TBARS) and activity/ 
amount of antioxidative enzymes (CAT, GSHPx, SOD).
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3. Carotid artery endarterectomy as a “clinical model 
of focal ischaemia/reperfusion injury
Since 1954, when carotid artery endarterectomy (removal of atherosclerotic 
plaque) was first performed in St Mary’s Hospital in London by Pickering and 
Rob (Eastcott, Pickering et al. 1954), this operation has been used to prevent 
brain stroke in patients with symptomatic or asymptomatic stenosis of the 
carotid arteries. Nowadays carotid artery endarterectomy (CAE) is a widely 
used and accepted method with appropriate guidelines and indications with 
reasonable benefits (owing to enormous work involving several large rando­
mized clinical trials in the last two decades). Unfortunately, CAE itself poses a 
risk of perioperative stroke and hyperperfusion syndrome (which is believed 
and associated partly with transient focal ischaemia/reperfusion event during 
surgery) (Rubio, Martinez-Yelamos et al. 2005), (Karapanayiotides, Meuli et al. 
2005). In recent years huge efforts have been made in refining both surgical and 
interventional techniques to reduce periprocedural stroke risk. Actually, the 
incidence of stroke during CAE has been reduced by use of perioperative 
aspirin and intraoperative heparin, encephalogram, and transcranial Doppler 
monitoring and shunting when it is necessary to prevent hemispheric ischaemia 
(Calligaro and Dougherty 2005). Despite these efforts in the recent decade, 
brain IRI as a phenomenon has been intensively studied to explore protection 
strategies against the IRI of the brain more thoroughly.
Carotid artery endarterectomy presents a discrete episode of focal cerebral 
ischaemia followed by reperfusion. In the scientific community it is believed 
that CAE is a relevant clinical model for studying transient focal IRI. Carotid 
artery endarterectomy as a model of brain IRI has both merits and drawbacks. 
The major disadvantage, in experimental terms, is lack of severity of infarction, 
since the short period of ischaemia, presence of collateral circulation, and use of 
shunts during surgery all combine to reduce the extent of injury, and clinically 
significant neuronal injury is rare (1991). However, major advantages of the 
model include its clinical substrate, controllability, and ability to estimate the 
severity of ischaemic insult with multimodality monitoring based on, e.g. 
transcranial Doppler, retrograde stump pressure, jugular venous saturation, and 
electrophysiological detection of the consequences of cerebral ischaemia 
(Kirkpatrick, Smielewski et al. 1995). Furthermore, recently it has been possible 
to monitor consciousness of the patient during CAE performed under local 
anaesthesia.
It is well known that the brain is at high risk from reactive species mediated 
injury due to its intensive aerobic metabolism, high content of PUFAs, quite 
large iron stores and relatively limited potency of antioxidant defences (Lee, 
Zipfel et al. 1999). Consequently, OxS has been implicated in cerebral IRI 
(Lipton 1999) and the latter has been shown to be prevented or ameliorated by 
an adequate and sufficient antioxidant administration in animal models
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(Sakamoto, Ohnishi et al. 1991; Yu, McCowan et al. 1992). The human body 
comprises an antioxidant network including enzymatic (e.g. superoxide 
dismutase, catalase and glutathione peroxidase) and nonenzymatic antioxidants 
(e.g. vitamin E, vitamin С and glutathione), to combat disorders caused by high- 
grade OxS. Under physiological conditions, this antioxidant system enables to 
control OxS, however, when these protective mechanisms are overwhelmed, 
injury of the surrounding tissues may occur (Starkopf, Tamme et al. 1997).
At present, despite previous studies of the products of lipid peroxidation 
(e.g. malondialdehyde, diene conjugates), information about the grade of OxS 
and as well as about the changes occurring on the systemic and cellular levels of 
OxS during carotid artery endarterectomy (CAE) is still limited. The expression 
of OxS (generalised/systemic or cellular) and the grade of OxS can be evaluated 
using an assay of appropriate biochemical indices.
4. Global brain ischaemia
Cerebral ischaemia-caused diseases and health conditions are a leading problem 
in Western countries. The latter can be exactly related to stroke, global brain 
ischaemia caused by cardiac arrest and temporary or permanent neurological 
disorders. During the last decades enormous efforts have been made to 
understand and discover the pathogenic cascade and mechanisms of cerebral 
ischaemia. Moreover, several agents and pro-drugs have been studied with the 
purpose to protect brain ischaemic event and reperfusion. Despite many clinical 
trials with different agents like NOS inhibitor, Na+ channel blockers, NMDA 
receptor antagonists, Ca2+ channel antagonist, etc. up to now no efficient agent 
has been discovered (Keynes and Garthwaite 2004), (Horn and Limburg 2001), 
(Moro, Cardenas et al. 2004), (Muir and Lees 2003).
4.1. Incidence of brain ischaemia
Stroke is the third leading cause of death and of serious long-term disability in a 
majority of industrialised countries, with an incidence of -350 per 100,000 
population aged 45-89 years (Warlow 1998). More than 80% of strokes are the 
consequence of permanent or prolonged occlusion, caused either by the 
thrombosis or embolism of one of the main or secondary cerebral arteries 
(Mohr, Caplan et al. 1978). In addition, cardiopulmonary resuscitation in 
patients of cardiac arrest, both within and outside hospital, succeeds in restoring 
of spontaneous circulation in about 70,000 patients per year in the United 
States. At least 60% of these patients subsequently die in hospital as a result of 
extensive brain damage, and only 3-10% of resuscitated patients are finally able 
to resume their former lifestyles (Krause, Kumar et al. 1986). Thus, brain injury
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by transient complete global brain ischaemia (cardiac arrest) and regiona in 
complete ischaemia (ischaemic stroke) afflicts a very large number of patients 
with death or permanent disability.
4.2. Cerebral injury during aortic arch surgery
There are two basic mechanisms that lead to ischaemic cerebral injury during 
aortic arch surgery. First, global ischaemia due to interrupted flow leads to 
temporary neurological dysfunction. This clinical situation is commonly be­
lieved to be self-limited and benign, but it may have subtle permanent se- 
quealae, which have been noted recently using detailed neuropsychometric 
testing that has shown alterations in the memory function. Second, macro- 
embolic injury leads to strokes, which are reported by most investigators as the 
only neurological consequences of these operations (Griepp and Griepp 1992), 
(Juvonen, Anttila et al. 2000).
4.3. Requirements and vulnerability of the brain
Compared with the other organs, the brain appears to be especially endangered 
with regard to generation and detoxification of ROS (reactive oxygen species), 
which are generated continuously during oxidative metabolism. The cells of the 
human brain utilize 20% of the oxygen consumed by the body, the brain’s 
energy requirement is more than seven times higher than that of the rest of the 
body, although this organ comprises only 2% of body mass (Vespa 2006). 
Different regions o f the brain utilize energy at different rates, and therefore 
some regions are more vulnerable to ischaemic injury than others. The earliest 
signs o f histological ischaemic injury are seen in the hippocampus (Petito, 
Feldmann et al. 1987). The main source of neuronal energy is generation of 
ATP by aerobic metabolism of glucose. In the absence of glucose and glycogen 
stores, the high rate of oxygen utilization requires a steady blood supply to 
provide the substrate as well as oxygen at a constant rate. High oxygen require­
ment of the brain indicates generation of a large quantity of ROS during 
oxidative phosporylation. Further, high iron content has been reported for some 
brain areas (Gerlach, Ben-Shachar et al. 1994), (Haacke, Cheng et al. 2005), 
which is able to catalyze generation of ROS. In addition, the brain might be 
especially vulnerable to ROS because it is rich in lipids with polyunsaturated 
acids (PUFA), the targets of lipid peroxidation. Moreover, the brain has only 
low to moderate superoxide dismutase, catalase and glutathione peroxidase 
activity compared with the kidney or the liver (Cooper and Kristal 1997).
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4.4. Brief description of cerebral ischaemia
Cerebral ischaemia results in a time-depend cascade of molecular events, 
including (i) rapid depletion of the intracellular ATP stores, (ii) anaerobic 
glycolysis, lactic acidosis, and membrane depolarization, (iii) glutamate excito- 
toxicity, (iv) entry of calcium, sodium, and water into cells, resulting in cell 
swelling, (v) activation of calcium-stimulated enzymes, mitochondrial dys­
function, reactive species overproducation, (vi) activation of the immune 
system, (vii) overexpression of particular genes, and (viii) increased neuronal 
death (Lerouet, Beray-Berthat et al. 2002), (Kato and Kogure 1999; Lee, Grabb 
et al. 2000). Furthermore, delay in recirculation during the reperfusion period 
increase the damage of the ischaemia-injured arterial wall; developing cerebral 
inflammatory response and excessive reactive species injury lead to damage of 
the brain tissue (Aronowski, Strong et al. 1997), (Scott and Gray 2000).
4.5. Cerebral ischaemia/reperfusion injury and glutathione system
Ischaemia/reperfusion injury is an important problem in clinical practice and it 
is associated with several different disorders like myocardial infarction, acute 
lower limb ischaemia, renal and hepatic transplantation, and ischaemic event,
i.e. a clamping episode during reconstructive surgery of the arteries and cerebral 
infarction. It is essential to have excellent knowledge of IRI to understand, 
interpret and solve complicated clinical situations (related to IRI) as well to 
provide high quality medical management and treatment.
Evidence has been accumulated over the last two decades supporting the 
idea that reactive oxidative species (ROS) as the hydroxyl radical, superoxide 
anion and hydrogen peroxide play a principal role in brain IRI (Cao, Carney et 
al. 1988), (Chan 1996), (Muralikrishna Adibhatla and Hatcher 2006). Simulta­
neously, it has been reported that glutathione (GSH), a crucial cellular 
antioxidant, depletion occurs both during focal brain ischaemia and after tran­
sient global brain ischaemia (Anderson, Nilsson et al. 2004), (Candelario-Jalil, 
Mhadu et al. 2001). Candelario-Jalil et al reported the results of a time course 
study of OxS in different regions during and after transient global brain 
ischaemia in gerbils. They found that after 5 min of bilateral carotid artery 
occlusion in gerbils, hippocampal GSH content significantly decreased in the 
early reperfusion phase and maximum reduction of hippocampal GSH was 
detected 48 and 72h after ischaemic event. Moreover, in the corpus striatum, 
GSH levels remained constant at all time points tested. Nor were there changes 
in GSH or GSSG during the ischaemic phase in the cortex, striatum and hippo­
campus. Further, GSHPx activity decreased significantly in the hippocampus 
48h and 72h after reperfusion. Yet no statistically significant differences in 
GSH-related enzyme activities were observed at any time point in the other 
brain regions (Candelario-Jalil, Mhadu et al. 2001). Additionally, Ahlemeyer et
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al reported that GSH depletion by BSO (buthionine sulfoximine), an inhibitor of 
glutathione synthesis, under conditions of serum deprivation (which itself 
increased mitochondrial ROS production (Atabay, Cagnoli et al. 1996), induced 
the increase in apoptotic neurons in cultured neurons (Ahlemeyer and 
Krieglstein 2000). These findings suggest that high GSH content is especially 
needed for survival of neurons under damaging conditions such as ischaemia/ 
reperfusion injury.
5. Glutathione, its biofunctions and analogues
Glutathione is a water-soluble tripeptide composed of the amino acids gluta­
mine, cysteine and glycine (L-y-Glu-L-Cys-Gly, MW 307, reduced glutathione, 
GSH). Reduced glutathione is a major low-molecular thiol compound in 
animals and plants, present in the millimolar range in mammalian cells (Meister 
and Anderson 1983); (Anderson 1997). In humans the highest levels of GSH 
are found in the RBCs, liver, pancreas, kidneys, spleen, eyes, lungs and 
intestinal cells. Molecules containing cysteine residue (the sulfhydryl group) 
readily participate in thiol-disulfide exchange. GSH is oxidized to glutathione 
disulfide (GSSG). The latter is maintained at less than 1% of total glutathione 
(Brigelius, Muckel et al. 1983); (Dickinson and Forman 2002) via rapid reduc­
tion back to GSH by a concerted action of NADPH and flavoenzyme 
glutathione reductase (GR). Hence, GSH and GSSG are the most typical 
representatives of the “glutathione world” in mammalian cells, with GSH being 
the principal player.
The isopeptide nature of the y-glutamyl linkage renders GSH resistant to 
most peptidases. The electronic structure of the sulfur atom underlies the high 
reactivity o f the thiol group to nucleophilic addition, redox reactions (e.g. via 
radical mechanism) and metal chelation. Due to these two special structural 
features, GSH is able to fulfil an impressive number and variety of biofunctions:
• GSH as the major cellular non-enzymatic antioxidant eliminates reactive 
species like hydroxyl radical, peroxynitrite, peroxides and N2O3 and plays a 
principal role in cellular defence against high-grade oxidative and nitrosative 
stress, mainly via co-operation with GSHPx, whereas rapid reduction of 
GSSG back to GSH by NADPH and glutathione reductase (GR) is needed 
(Anderson, Underwood et al. 1989; Meister 1994; Lucente, Luisi et al. 1998; 
Griffith and Mulcahy 1999);
• GSH is involved in restoration of the thiol groups of proteins (maintenance 
of haemoglobin, other proteins and enzymes in active forms) and coenzyme
A. It is required for stabilization of cell membranes and for synthesis of 
proteins, nucleic acids, leukotrienes and prostaglandins (Anderson 1997; 
Valencia, Hardy et al. 2001; Pastore, Federici et al. 2003).
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• GSH is used for detoxification of several xenobiotics by GSTs, involved in 
the transport of nitric oxide, and in the modulation (glutathionylation) of 
several key-enzymes and proteins (GAPDH, phosphorylase, creatinine 
kinase, Ras) (Anderson 1997), (Karelson, Mahlapuu et al. 2002; Townsend, 
Tew et al. 2003);
• GSH is the cell redox regulator and the glutathione redox ratio (GSSG/GSH) 
as a redox buffer modulates the action of numerous redox-sensitive proteins 
(including a number of transcription factors) (Schafer and Buettner 2001), 
(Filomeni, Rotilio et al. 2002), (Huang and Huang 2002).
GSH plays a crucial role in OxS process; it provides a first line defence against 
ROS as a scavenger of free radicals and reducer of H20 2. The second line of 
defence against OxS, related to GSH, is associated with the glutathione- 
dependent enzymes — GSHPx and GR. GSHPx catalyses the conversion of 
H20 2, produced by SOD, with the dismutation of the superoxide anion (0 2 ), to 
H20 2. The GR contains flavin adenine dinucleotide and uses reducing equi­
valents from NADPH to convert GSSG back to 2GSH (Pastore, Federici et al. 
2003).
An impressive spectrum of the biofunctionality of GSH and depletion of 
cellular GSH during infection, intestinal lesions, major trauma, hypovolemic 
shock, and sepsis and ischaemia/reperfusion injury explains why pharmaco- 
clinical strategies have begun to use the glutathione system as the target. These 
strategies that maintain or replenish the depleted stores of GSH may minimize 
tissue injury. There are several ways to maintain or restore cellular GSH levels 
in the body, for example, parenterally, intraarterially, however despite high 
concentrations of GSH used, the results in clinical practice have remained 
modest. Thus, administration of GSH to guarantee its necessarily very high 
(mM) physiological cellular concentration has substantial limitations like rapid 
extracellular degradation in the gut and circulation, poor penetration of the 
blood-brain barrier, limited direct uptake into all cell types or its absence. The 
bioavailability of cysteine is a principal limitation for the de novo synthesis of 
cellular GSH and markedly elevated administration of cysteine cannot restore/ 
maintain GSH levels. Cysteine is autooxidized being toxic for cultured cells and 
newborn mice (Anderson 1998). Many studies have been published showing 
beneficial effect of cysteine precursor like N-acetyl-L-cysteine (NAC) against 
ischaemic brain damage in gerbils and in rats (Cuzzocrea, Mazzon et al. 2000). 
(Sekhon, Sekhon et al. 2003). Further, NAC-enriched cold-blood cardioplegia 
diminished myocardial injury during the coronary artery bypass surgery (Kora- 
maz, Pulathan et al. 2006).
The esters of GSH are readily taken up by cells and are de-esterified in cells 
to provide GSH. These esters have a protective effect against cerebral brain 
ischaemia in rats (Anderson, Nilsson et al. 2004), (Yamoto M 1993).
However, it seems that one perspective approache might be designing and 
studying analogues of GSH, which are promising candidates for increasing
GSH levels to improve or maintain cellular defences related to GSH system. It 
would be of significant pharmaco-clinical interest to design analogues of GSH 
with higher hydrophobicity (to improve penetration through biomembranes), 
which are also able to mimic or even exceed the functionality (including the 
antioxidative potency) of GSH itself and which cannot be used by glutathione 
S-transferase. Such GSH-like new compounds would expand the possibility to 
support some parts of the glutathione system and may have an impact, as an 
adjuvant therapeutic factor, for instance, in the case of high-grade OxS when the 
production of the potent pro-oxidant GSSG is powerful.
On the basis of mentioned above understandings a novel glutathione ana­
logue, named UPF1, 4-MeO-Tyr-y-Glu-Cys-Gly; MW 483.5, (assignee Vulpes 
Ltd., no. 110035500, PCT/SE01/01351) is a water soluble acidic peptide has 
been designed at Department of Biochemistry of Tartu University. To improve 
the antioxidativity of GSH, we added additional nonproteinogenic amino acid 4- 
methoxy-phenylalanine to the GSH trimer N-terminus, increasing in this way 
the hydrophobicity o f GSH as well as introducing the methoxy group. 
Consequently, one part of the current thesis characterises this novel glutathione 
analogue and explores its effect on global brain ischaemia in rats.
6. Animal models of brain ischaemia
For studies of brain ischaemia many different animal models have been used 
during the last two decades. These models can be predominately divided into 
models o f global and focal brain ischaemia. Models of global brain ischaemia 
can be associated with cardiac arrest or with aortic arch reconstructive surgery 
(which may lead to selective neuronal necrosis). At the same time, models of 
focal brain ischaemia are considered to be of greater relevance in acute 
ischaemic stroke due to brain infarction (Macrae, Robinson et al. 1993). Focal 
brain ischaemia can be roughly categorized into two types: permanent and 
reversible. Permanent focal ischaemia results in the appearance of a region of 
ischaemic damage (the core), while degenerative changes are seen to spread 
from this region. The aim is therefore to attempt to reduce the spread of damage 
by protecting the penumbral area at risk. It is questionable whether total and 
permanent cessation of blood flow in a brain region because of thrombus 
disintegration and endogenous thrombolysis occurs clinically in a majority of 
strokes. Therefore, reversible occlusion models have also been developed and, 
in this situation, damage will be the result of both ischaemia and the con­
sequences of reperfusion (Mohr 1993).
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6.1. Models of focal brain ischaemia
The techniques of focal brain ischaemia are available for both permanent and 
reversible occlusion. The model of middle cerebral artery occlusion is 
applicable in several species. Variation in technique allows some selection 
regarding which cerebral areas are affected. This model has been used in 
hypertensive rat strains. Occlusion of the artery can be induced by techniques 
including cauterization, clips and threads (filaments), endothelin 1 administ­
ration, or photochemically by induced thrombolytic occlusion (Karpiak, 
Tagliavia et al. 1989) (Ginsberg and Busto 1989) (Macrae, Robinson et al. 
1993),(Kuge, Minematsu et al. 1995),(Longa, Weinstein et al. 1989).
6.2. Models of global brain ischaemia
There are basically three different models of global brain ischaemia: gerbil 
bilateral carotid occlusion, two-vessel rat occlusion with simultaneously in­
duced hypotension and, finally, four-vessel rat occlusion. It should be em­
phasized that the literature offers several modifications of the above mentioned 
models. Therefore, different scientific centres and communities have obtained 
similar or mostly similar results using, for instance, the rat model of four-vessel 
occlusion, while animal experiments have been performed with minor or major 
modifications. These modifications of animal models produce variation of 
results and mixing up of many scientific conclusions that are unfortunately not 
comparable to each other.
The model of gerbil bilateral carotid occlusion has met wide popularity 
because of the relative ease of the surgical techniques involved. Also this model 
is highly suitable for screening purposes. By the way, the gerbil (Meriones 
unguiculatus) does not have connecting arteries between the arterial system of 
the internal carotid arteries and the vertebral arteries. The rat model of global 
brain ischaemia includes both two- and four-vessel occlusion models, the 
former requiring induction of hypotension and the latter involving, according to 
the original method described by Pulsinelli, a two-stage procedure (Pulsinelli 
and Brierley 1979; Pulsinelli, Brierley et al. 1982). In the current thesis a model 
of global brain ischaemia was developed and adapted to a one-stage procedure. 
Yet it should be emphasized that all global brain ischaemia methods, as the 
name implies, result in ischaemia over a large proportion of the brain (com­
monly the forebrain) and involve a variable period of transient ischaemia 
(Pulsinelli, Levy et al. 1983).
Unfortunately, all of the above described models of brain ischaemia have 
drawbacks. For instance, the gerbil bilateral carotid artery occlusion model has 
variable outcome due to variations in cerebral circulation. Also, it is difficult to 
perform physiological measurements in these small animals; and the rat two- 
vessel occlusion model plus the rat hypotension model requires inducement of
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hypotension, post-ischaemic seizures are quite often observed, etc. (Gins erg 
and Busto 1989). The main drawback, high mortality rate in spontaneously 
breathing animals, can be noted and observed when implementing the rat model 
of four-vessel occlusion model. The mortality rates published in the original 
description of the model of global cerebral ischaemia were 10% and 40% after 
20 min and 30 min of bilateral carotid occlusion, respectively (Pulsinelli, 
Brierley et al. 1982). The corresponding rates were up to 75% higher in other 
laboratories where a similar model was used (Rosenbaum, Grotta et al. 1990), 
(Vered, Bar-Joseph et al. 1994). In a study by Herguido et al., mortality rate for 
20 min of global brain ischaemia was 34% in the perioperative period and 50% 
in the postoperative period (Herguido, Carceller et al. 1999). Moreover, it has to 
be emphasized that in our animal experiments (10 min of global brain ischae­
mia) general mortality rate was 38% (the lowest in the UPF1 reperfusion group 
and the highest in the vehicle group, 11% and 45%, respectively). Further, to 
achieve correctly interpretable data, using the rat four-vessel occlusion model, it 
is most important to adhere to exclusion criteria. Rats that remain unresponsive 
throughout the ischaemic period, or rats whose body temperature drop below 
36.0C0 and rises above 37.5C°, or rats that develop epileptic seizures, or rats 
that require assistant pulmonary ventilation perioperatively are excluded from 
the study group. Consequently, when mortality rate is high and the model 
requires several a priori postulated exclusion criteria, the survived animals and 
the included animals belong to a particularly ischaemia-resistant subpopulation. 
Therefore much effort is needed to reduce animal mortality to as minimum level 
as possible and this not only for ethical and practical reasons but also in order to 
eliminate this source of bias.
Moreover, during animal experiments of brain ischaemia it is mandatory to 
keep the body temperature of the animal in the physiological range and to 
maitain this condition during the postoperative period. Thus, the deleterious 
effect of hyperthermia on the outcome of stroke in both rodents and humans has 
long been recognised (Thornhill and Corbett 2001). In contrast, the beneficial 
effect o f hypothermia is well established in animal models, but there is still 
limited evidence of its effectiveness in clinical trial settings (Schwab, 
Georgiadis et al. 2001).
Furthermore, on the basis of our experience and according to literature data, 
to achieve well reproducible animal experiments of brain ischaemia, it is 
obligatory to observe very carefully clinical conditions of the animal (breathing 
pattern, temperature, blood pressure, blood gases). Moreover, in critical life 
threatening situations during animal experiments one must quickly undertake 
necessary actions (treatment possibilities in correct order) to ensure survival of 
animals after brain ischaemia.
Finally, we would like to emphasize that elaboration of an animal model like 
a rat model of four-vessel occlusion is a very time consuming and difficult task. 
Unfortunately, it is almost impossible to merely take a scientific description of a 
complicated animal experiment from some publication and to develop, during a
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short period of time, a well reproducible animal model. Therefore, according to 
the experience obtained from this work we believe that it is mandatory to 
perform well organized multistage pilot studies. Moreover, we suggest that for 
high quality animal experiments it is obligatory to have dedicated and well- 
oriented team members and who have possibilities of consulting specialists in 
the same scientific area from other research centers.
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AIMS OF THE STUDY
The general purpose of this study was to explore ischaemia/reperfusion 
injury associated with oxidative stress during different vascular re­
constructive operations and to examine the novel glutathione analogue 
UPF1 in vitro, in primary cell cultures and in a rat model of global brain 
ischaemia.
The goal of the current study was divided into specific aims as follows:
1. Elective abdominal aortic aneurysm repair —  to study the time course of 
oxidative stress -  both the manifestation (systemic, cellular) and nature 
(low or high grade) of oxidative stress
2. Endarterectomy of the carotid artery — to study the time course of oxida­
tive stress — both the manifestation (systemic, cellular) and nature (low 
or high grade) of oxidative stress
3. Using in vitro and in vivo methods, to clarify the effects of a potent 
antioxidant, the glutathione analogue UPF1 —  its antioxidative nature 
and possible neurotoxicity —  and to establish its possible protective 
character against IRI using a rat model of global brain ischaemia.
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MATEM AL AND METHODS
7. Time-course measurement of oxidative stress during 
vascular reconstructions
7.1. Presurgical and surgical procedures
7.1.1. Elective abdominal aortic aneurysm repair
Presurgical procedures were performed as follows: one hour before surgery, 
morphine and dehydrobenzperidol (Droperidol) were given intramuscularly as 
premedication. Arterial and Swan-Ganz pulmonary arterial catheters were in­
serted in all patients. Induction of anesthesia was performed with atropine, 
etomidate and phentanyl. Endotracheal intubation was carried out with suc- 
cinylcholine. Muscle relaxation was achieved with pipecuronium and analgesia 
was performed with continuous infusion using fentanyl 3-4 jig/kg/h. The lungs 
were ventilated with isoflurane up to 1.5 vol. % with oxygen and N20. During 
AAA surgery, the central hemodynamic parameters were checked and measured 
with a Swan-Ganz catheter at three time points: before surgical manipulation, 
after aortic cross clamping and at the end of the operation. Before reperfusion, 
mannitol (0.5 g/kg) was administered regularly. We performed elective AAAR 
as follows: a collagen impregnated woven prosthesis was inserted; the proximal 
anastomosis was done end-to-end to the abdominal aorta below the renal arte­
ries and the distal anastomoses were done end-to-side to the common femoral 
arteries or end-to-end to the common iliac arteries. Each patient received 
intravenously 3000 units of heparin before the cross clamping of the abdominal 
aorta.
7.1.2. Carotid artery endarterectomy
After premedication with midazolam, anaesthesia was induced with atropine, 
etomidate and fentanyl. Endothracheal intubation was carried out with suc- 
cinylcholine. Muscle relaxation was achieved with pipercuronium and analgesia 
was performed with continuous infusion using fentanyl 3-4 jj.g/kg/h. The lungs 
were ventilated with isoflurane up to 1.5 vol. % with oxygen and N20 . All 
patients were mechanically ventilated to maintain normocapnia with PaC02 of 
38 to 41 mmHg. In all patients an arterial catheter was inserted, ECG, end-tidal 
capnometry, and changes in arterial blood pressure were continuously recorded. 
A neurological examination was performed immediately after the patient 
awakened, 1 hour later, and then daily until the patient was discharged. During 
carotid surgery, we did not use transcranial Doppler ultrasound, or the moni­
toring of somatosensory evoked potentials, or electroencephalography. Each
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patient received 3000 units of heparin before cross clamping. During end­
arterectomy blood pressure was raised and maintained pharmacologically (at 
least at 10 mmHg of mean blood pressure) with phenylephrine above individual 
blood pressure baseline values in each patient (Calligaro and Dougherty 2005).
7.2. Blood sampling and time points during vascular reconstructions
7.2.1. Elective abdominal aortic aneurysm repair
Samples were obtained from the peripheral arterial line (radial artery) at four 
time points during elective AAAR: (i) before induction of anaesthesia; (ii) 5 
min after infrarenal abdominal aortic cross-clamping; (iii) 5 min after the 
removal of the infrarenal abdominal aortic cross-clamp and (iv) 30 min after the 
removal of the infrarenal abdominal aortic cross-clamp.
7.2.2. Carotid artery endarterectomy
Blood samples were collected regularly from the peripheral arterial line (the 
radial artery) at four time points: (i) before anaesthesia, (ii) 5 min after carotid 
artery clamping; (iii) 5 min and (iv) 30 min after declamping during CAE.
Blood was taken into 7 ml sterile lavender vacutainer tubes and promptly 
transported to the laboratory for analysis. The serum was separated by centri­
fugation (4 X 600g by discarding the plasma and the top layer cells) and kept in 
plastic tubes at -20°C until analysis.
7.3. Assessment of oxidative stress indices
All measurements of oxidative stress markers were performed in triplicate 
within 4 h of blood sampling. The means were calculated and used for statistical 
analysis. The haemolysed samples were excluded from analysis. All reagents 
were purchased from Sigma (St. Louis, Missouri, USA).
7.3.1. Lipid peroxidation
Lipid peroxidation (LP) products were detected in serum to avoid the possible 
influence of the substances required for plasma preparation (Annuk, Zilmer et 
al. 2001). LP samples were treated with antioxidant butylated hydroxytoluene 
(BHT) twice, immediately after obtaining and before adding the test reagents to 
suppress artefact changes during handling and assay procedures (Annuk, Zilmer 
et al. 2001).
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At present, both serum and plasma were used as routine test samples to 
check LP in the body, to investigate free radical injury, or to establish the 
diagnosis of LP-mediated diseases. In the process of LP (i.e., free radical 
conversion of PUFAs residues), the first stage, consisting of the molecular 
rearrangement of double bonds in PUFAs residues of lipids, leads to formation 
of DC. Conversion of DC yielded secondary stable products (aldehydes, 
alkenals) of LP. The latter were measured as thiobarbituric acid reactive 
products (TBARS).
Serum levels of DC were measured according to the methods described 
previously (Regnstrom, Strom et al. 1993), with some minor modifications. 
Briefly, the samples (150 jliI) + (150 jj.1) of 0.9% NaCl (reagent blank contains 
only isotonic saline) were incubated at 37°C for 25 min, 0.25% BHT (150 ц.1) 
was added and the lipids were extracted by heptane/isopropanol (1:1). Then the 
samples were acidified by 5 mol/1 hydrochloric acid and extracted by cold 
heptane (1600 ц1). After centrifugation (for 5 min at 3000 rpm) and absorbance 
of the heptane fraction, they were measured spectrophotometrically at an 
absorbance maximum between 220 and 250 nm. To correct the results for 
hemodilutation, protein content in the samples was determined according to 
(Lowry OH 1951).
Serum levels of TBARS were measured according to the method of Ohkawa 
et al. (Ohkawa, Ohishi et al. 1979) with a few minor modifications (Annuk, 
Zilmer et al. 2001). Briefly, the samples were incubated with 475 |iM Fe2+ at 
37°C for 30 min. After incubation, BHT (0.25%) was added to the samples (250 
fil), which were then treated with an acetate buffer (pH 3.5) and heated with the 
presents of the TBA solution (1% 80°C, 70 min). Then the samples were cooled 
and acidified (5 mol/1 hydrochloric acid). After extraction with cold butanol, the 
samples were centrifuged and the absorbance of butanol was measured at 534 
nm.
7.3.2. Total antioxidative capacity
It is suggested that the blood antioxidative system is able to control the level of 
reactive oxygen species. Among the serum antioxidants, one particular compo­
nent can not fully reflect the protective potency of whole blood. Hence, when 
assessing serum TAC, GSH, GSSH, SOD, GSHPx and CAT, complex measure­
ments of serum antioxidant potency were performed.
Serum TAC was measured through the ability of the serum samples to in­
hibit linolenic acid (LA) peroxidation. In preliminary experiments we 
established that this procedure shows good accordance with the total antioxidant 
activity method (Annuk, Fellstrom et al. 2001). Briefly, standard LA in isotonic 
saline (400 ц1), sodium dodecyl sulphate (15 ц1), and serum (30 \i\ 1:3:3 in 
isotonic saline) were incubated in the presence of 200 fimol/iron at 37°C for 
60 min. BHT (0.25%) was added, then the samples were treated with an acetate
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buffer (pH 3.5), heated with the presents of the TBA solution (1%, 80 , 
35 min) and assessed for TBARS. The results were expressed as the percentage 
of inhibition of LA peroxidation, induced by the serum samples.
SOD and GSHPx were measured according to special protocols using 
commercially available kits (Randox Laboratories Ltd, Ardmore, UK) (1998). 
CAT was measured using TBARS according to a method described in the 
literature (Goth 1991). Total glutathione (TGSH) and oxidized glutathione 
(GSSG) were measured by the enzymatic method of Tietze (Tietze 1969), 
which was slightly modified for the present study (Annuk, Fellstrom et al. 
2001). The content of GSH was calculated as the difference between the total 
amounts of glutathione and GSSG (TGH-GSSG).
8. Glutathione and UPF1 as protective molecules
First, we tested the possible antioxidativity of UPF1 to verify the hydroxyl 
radical scavenging effects, and second, we compared the antioxidativity of 
UPF1 to that of GSH. Briefly, we determined the antioxidativity of UPF1 as 
described by Barreto et al. (Barreto, Smith et al. 1995), using terephthalic acid 
(THA) as the chemical dosimeter for hydroxyl radicals. The THA dosimeter 
solution contained 10 mM THA in a 14.75 mM sodium phosphate buffer at pH 
7.5 which was used as the control. Hydroxyl radicals were generated via the 
Fenton reaction by adding CuS04 and H20 2 to the dosimeter solution in order to 
achieve the final concentration of 10 juM and 1 mM, respectively. The effect of 
suppression of hydroxyl radicals was measured by a spectrofluorometer (Perkin 
Elmer LS5) at 312 nm excitation and at 426 nm emission (Pahkla, Zilmer et al. 
1998). The IC50 values were determined by sigmoid dose-response (viable 
slope) analysis using the GraphPad Prism version 3.0 (GraphPad Software Inc., 
San Diego, CA).
9. Primary cell cultures — cerebellar granular cell culture and 
GSH and UPFl
Primary cultures of cerebellar granule cells were prepared according to the 
method described by Gallo et al, with minor modifications (Gallo, Ciotti et al. 
1982). Briefly, the cerebelli were dissected from 8-day-old Wistar rats and the 
cells were dissociated by mild trypsinization followed by trituration in a 0.004% 
DNAse solution containing 0.05% soybean trypsin inhibitor. The cells were 
resuspended in Basal Medium Eagle with Earle’s Salts containing 10% heat- 
inactivated foetal bovine serum, 25 mM KC1, 2 mM glutamine and 100 fj.g/ml 
gentamycin. The cell suspension was seeded into 40-mm, dishes pre-coated 
with 5 (_ig/ml of poly-L-lysine with a density of 1.3-1.4 x ю 6 cells/ml. The cell
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cultures were grown for 8 days in a humidified 5 % C02/95% 0 2 atmosphere at 
37°C. After 24 hours of incubation 10 fiM cytosine-ß-arabino-furanoside was 
added to the culture medium to prevent proliferation of nonneuronal cells. 
Seven- or 8-day-old cultures were used in the current experiment.
We treated each well with 2 ц1 of either GSH (as the negative control) or 
UPF1, both mixed with 50 ц1 of the medium in final concentrations 0.01, 0.1, 
10 and 100 цМ. After 24 hours of incubation, cell viability was assessed by a 
trypan blue assay. The cultures were washed with phosphate buffered saline and 
were then incubated with a 0.4% Trypan blue solution at room temperature for 
10 min. Only dead neurons were stained with Trypan blue (Tymianski, Charlton 
et al. 1993). The number of Trypan blue positive cells and viable non-stained 
cells were counted. Approximately 1000 cells per three fields in each well were 
counted to determine the viability of the cell cultures. For each concentration, 
three wells were used.
10. Rat model of global brain ischaemia
Animal experiments were performed using a rat model of four-vessel occlusion. 
The Ethics Committee of the University of Tartu approved the experimental 
protocol. Male Wistar rats weighing 270-350g were used. The four-vessel occlusion 
model of forebrain ischaemia, described by Pulsinelli and Brierly, was employed 
with some modification (Pulsinelli and Brierley 1979; Pulsinelli and Buchan 1988).
Briefly, the rats were fasted overnight; anaesthesia was induced with 3% 
halothane in oxygen (at a rate of 0.9 1/min), followed by orotracheal intubation, 
and the animals were respirated during the surgical procedure with a respirator 
(TSE Animal Respirator “Advanced”) (Jou, Tsai et al. 2000). A rectal tem­
perature probe was inserted and body temperature was monitored and 
maintained at 37.0°C using a heating pad. First, the rats were mounted on a 
head holder and tilted downward by approximately 30°. The vertebral arteries 
were coagulated through both alar foramina's of the first cervical vertebra. The 
bilateral common carotid arteries were exposed via a ventral midline incision 
and transient global forebrain ischaemia was induced for 10 minutes by 
clamping both common carotid arteries with microvascular clamps.
During ischaemia the animals were monitored for body temperature, 
respiration pattern, loss of righting reflex, unresponsiveness, corneal reflexes, as 
well as for fixed and dilated pupils. Restoration of blood flow in the carotid 
arteries was confirmed by careful visualisation. In the sham-operated group of 
rats, both vertebral arteries were cauterised and both common carotid arteries 
were exposed but not clamped.
The rats which remained unresponsive throughout the ischaemic period, 
those whose temperature dropped below 36.0°C, those which developed epi­
leptic seizures and those which required persistent assisted pulmonary ventila­
tion postoperatively were excluded from the study.
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10.1. Experimental protocol of global brain ischaemia
The animals were assigned randomly into one of the following groups, sham 
group; vehicle group of four-vessel-occlusion (4VO) rats, which were given 
isotonic saline (up to 0.5 ml) into the external jugular vein; 4VO rats, which 
were given UPF1 into the external jugular vein 20 minutes before inducing 
global brain ischaemia (UPF1 preischaemic); 4VO rats, which received UPF1 
immediately before reperfusion (UPF1 reperfusion).
The UPF1 was injected in a dose of 0.9 mg/kg dissolved in a saline solution 
up to 0.5 ml into the jugular vein as a bolus dose during 30 seconds. This dose 
was selected proceeding from both the calculation derived from the measure­
ments of the scavenging potency of UPF1 and from the analysis of some 
previously published reports (Marin, Comet et al. 2000), (Chabrier, Auguet et 
al. 1999).
11. Histological evaluation of the pyramidal cells 
of the dorsal hippocampus
Seventy-two hours following ischaemia, the animals were killed by an intra- 
peritoneal injection of fentanyl-fluanisone and midazolam for perfusion fixation 
of the brain with phosphate-buffered paraformaldehyde (4%) at pH 7.4 after 
rinsing with 0.9% saline by cannulating the ascending aorta transcardially.
The representative coronal sections (7 jim) of the dorsal hippocampus of the 
paraffin-embedded brains were sliced at 200 ц т  intervals and were stained with 
cresyl-violet. The number of surviving neurons in the CA1 area of the dorsal 
hippocampus was counted to quantify the extent of ischaemic neuronal injury. 
To minimize bias in counting, all slices were assigned randomly and counted 
separately by three technicians blinded to the experimental protocol. To 
standardize the counting procedures, a virtual frame lying at the middle portion 
of the dorsal hippocampus was used. The size of the virtual frame was 0.4 x 
1 mm and its major axis proceeded along the pyramidal cell layer as in Bae et 
al. (Bae, Lee et al. 2000) (Figure 1). All viable neurons within six frames in the 
left and right CA1 regions of the three coronal sections of the dorsal 
hippocampus for each animal were counted under the criteria proposed by 
Kirino (Fortuna, Pestalozza et al. 1997) at 832-fold magnification using an 
image analysis software package (AnalySIS 3.0; Soft Imaging System, Munster, 
Germany). Both sides of the dorsal hippocampus were counted separately and 
the average number of viable pyramidal cells in each coronal section of the 
brain was selected as the representative value.
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Figure 1. Low-power (x4.5) light micrograph of a 7 pm coronal section stained by 
cresyl violet, showing the localisation of the counting frame at the middle part of the 
region of CA1. The size of the virtual frame was 0.4 x 1 mm and its major axis was 
along the pyramidal cell layer (scale bar = 1000 pm).
12. Statistical analysis
The data were recorded and used for statistical analysis with the GraphPad 
Prism version 3.0 (GraphPad Software Inc., San Diego, CA). For repeated 
measurements over the time course of elective carotid artery endarterectomy, 
the non-parametric Friedman test was used for comparison of the preoperative 
value with the values for the other time points, correcting multiple comparison 
with the Dunn test. The results are presented as the mean ± standard error of the 
mean (SEM) in the text and in the tables. The limit of a statistically significant 
P value was set at 0.05.
All experimental data are shown as mean ± SEM. A normal distribution of 
the number of viable neurons was established using the Shapiro-Wilk test (p > 
0.05). The mean number of viable pyramidal cells in the TJPF1 treated groups 
was compared with the number of viable pyramidal cells in the vehicle-treated 
group by the one-way ANOVA test with the Dunnett correction using the 
statistical program GraphPad Prism version 3.0. A value of P < 0.05 was 
considered to indicate statistical significance.
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RESULTS
13. Oxidative stress during elective aortic aneurysm repair
This study examined the time-course of the indices of systemic and cellular 
OxS in 18 patients undergoing elective AAAR (Table 1). There were no 
complications associated with surgery, or death cases during the study period. 
Average perioperative blood loss was 2033 ml and blood transfusion was 
965 ml. A cell-saver was used during two abdominal aortic aneurysm resec­
tions. However, two patients died during the postoperative course, one from 
recurrent myocardial infarction and the other from multiple organ failure 
resulting from aspirated bilateral bronchopneumonia.
Table 1. Main clinical characteristics of the study group
Female/male 3/15
Mean age, y 67.0, range 53-77
Abdominal aortic cross-clamping time (min) 61.3±3.9
Mean transversal diameter of abdominal aortic aneurysm (cm) 1 7.8, range 5.8-9.7
Operating time (min) 229.6±11.1
Smokers 5 of 18 (28%)
Preoperatively existing diseases
PAD 10 of 18 (56%)
Hypertension 11 of 18 (61%)
Symptomatic myocardial ischemia 9 of 18 (50%)
Chronic respiratory disease 1 of 18 (6%)
Diabetes_______________________________________________0 of 18 (0%)_______
PAD, peripheral arterial diseases
1 The diameter of AAA was determined preoperatively by Doppler ultrasound mea­
surement
Arterial CAT revealed a significant elevation (96.0 ± 11.7) 30 min after aortic 
clamp removal in comparison with the preclamping value (56.9 ± 7.3) and 
5 min after the application of the aortic crossclamp (63.7 ± 4.6). Simulta­
neously, changes were observed in GSHPx 30 min after the removal of the 
abdominal aortic clamp. The GSHPx was significantly elevated (51, 5%) and 
TAC was decreased (31.4%) in comparison with the corresponding value at the 
preclamping time point. The markers of lipid peroxidation, DC and TBARS, as 
well as the glutathione redox status and the antioxidant enzyme, SOD, did not 
show any significant changes during AAA surgery (Table 2).
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Table 2. Comparative dynamics of the systemic and cellular of OS indices during 
elective AAAR (n = 12-18).
Time points during AAAR A В С D
TBARS, nmol/ml 1.4±0.1 1.3±0.1 1.5+0.1 1.4+0.1
DC, (imol/ml 24.1±1.3 23.7+1.5 23.0+1.4 21.1+1.2
TAC, % 36.5+1.4* 35.2±1.3 33.5+1.1 31.4+1.2
CAT, U/l 56.9+7.3* 63.7±4.6** 67.9+5.8 96.0+11.7
SOD, U/gHb 719.2±35.1 648.4±41.4 670.9+34.3 748.3+46.8
GSHPX, U/gHb 39.9+3.3* 41.2±3.5 46.2+5.9 51.5+3.9
GSSG/GSH 0.3±0.03 0.3+0.03 0.4+0.07 0.3+0.04
*p < 0.05 for differences between the values of time points A and С 
** p < 0.05 for differences between the values of time points В and С
A. before induction of anesthesia
B. 5 min after infrarenal abdominal aortic cross-clamping
C. 5 min after removal of infrarenal abdominal aortic cross-clamp
D. 30 min after removal of infrarenal abdominal aortic cross-clamp
14. Oxidative stress during carotid artery endarterectomy
The time-course of the indices of systemic and cellular OxS was studied in 24 
patients undergoing elective CAE diagnosed symptomatic carotid artery 
stenosis. There were no fatal complications associated with surgery. However, 
two patients had postoperative permanent neurological deficit. One patient 
became hemiparetic and the other patient had apalic syndrome. Both patients 
had had cerebral infarction preoperatively, which had been identified with CT, 
and these patients had minor neurological deficit before surgery. The 
indications for CAE are shown in Table 3. No vascular shunt was used during 
CAE. Seventeen patients of 24 took aspirin (Lannacher, Austria) as antiplatelet 
medication, but none of the patients took antioxidants.
Arterial TBARS revealed a statistically significant increase (1.7±0.1) 5 min 
after carotid clamp removal in comparison with the preclamping value 
(1.5±0.1). At the same time, an elevation in CAT and GSHPx (89±9 and 38±3, 
respectively) was observed 5 min after declamping in comparison with the 
corresponding value at the preclamping time point. The other markers as DC, 
SOD and TAC did not show any statistically significant changes during CAE. 
Simultaneously, the glutathione redox ratio did not reveal any changes during 
CAE, either (Table 4).
35
Table 3. Main clinical characteristics of the study group
Female/male 
Mean age, y
Clamping time of the carotid artery (min)
Standard endarterectomy versus eversion endarterectomy 
Indication for carotid endarterectomy 
Symptomatic carotid artery stenosis 
(trombembologenic plaque)1 60-70%
Symptomatic carotid artery stenosis (> 70%)
Diseases existing preoperatively
Cerebral microinfarcts
PAD
Hypertension
CHD
Diabetes
PAD, peripheral arterial disease
CHD, coronary heart disease
1 Detected by Doppler ultrasound measurement
Table 4. Comparative dynamics of the indices of systemic and cellular of OxS during 
CAE (n= 17-24)
Time points during CAE A В С D
TBARS, nmol/ml 1.510.1 1.6+0.1 1.7+0.1* 1.6+0.1
DC, |imol/ml 29.7+2.1 30.6+2.1 28.5+1.9 27.9+1.9
TAC, % 36±1 35±1 35+1 35+1
CAT, U/l 65±6 84±7 89+9* 85+13
SOD, U/gHb 674±31 686+39 649+43 655+44
GSHPX, U/gHb 36±3 37+3 38+3* 37+3
GSSG/GSH 0.9+0.17 1.0+0.19 0.9+0.19 1.0+0.23
*p < 0.05 for the differences between the values of time points A and С
A. before induction of anesthesia
B. 5 min after carotid artery clamping
C. 5 min after removal of the carotid artery clamp
D. 30 min after removal of the carotid artery clamp
5/19
68.0, range 44-84 
18±1.1 
13 vs 11
6 of 24 (25%)
18 of 24 (75%)
2 of 24 (8%)
13 of 24 (54%)
10 of 24 (42 %)
3 of 24 (13%)
1 of 24 (4%)
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15. Glutathione and UPF1 — their antioxidative effect
We found that UPF1 possesses an evident hydroxyl radical scavenging nature in 
vitro. It means that linking of hydrophobic moiety with an attached methoxy 
group to the N-terminus of GSH increased dramatically the antioxidative 
properties of peptide.
The IC50of UPF1 (20.5±2.3 fiM) was about 60 times lower compared with 
the corresponding value of GSH (1С50=1254.1±382.2цМ) (Figure 2).
k)g[antioxidant]
Figure 2. Comparison of antioxidative potency of UPF1 (filled triangles) and GSH 
(empty squares).
16. Common characteristics of glutathione and 
UPF1 in primary cell cultures
The viability of the cerebellar granule cells treated with UPF1 (ranging from 
90% to 87%) was similar to that of the non-treated and GSH-treated controls 
(ranging from 92% to 90%) at each concentration used (even at a concentration 
of 100 fiM the survival data were similar to the corresponding data for the 
control group) (Figure 3).
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Figure 3. Survival of the cerebellar granule cells at different concentrations of UPF1. 
Control: utreated cells.
We suggest that the current results point to a beneficial, i.e. non-toxic, trend of 
UPF1 in primary cultures.
17. UPF1 and global brain ischaemia/reperfusion injury in rats
Sixty-three rats were used in the animal experiments; 24 animals died and 16 
rats, which remained unresponsive throughout the ischaemic period, those 
whose temperature dropped below 36.0 °C, those which developed epileptic 
seizures and those which required persistent assisted pulmonary ventilation 
postoperatively were excluded from the study. Five rats in the sham group, 8 
rats in the vehicle group, 5 rats in the UPF1 preischaemic group, and 5 rats in 
the UPF1 reperfusion group completed the study.
The representative sections, obtained 72 hours after ischaemia and stained 
with cresyl violet, are shown in Figure 4. The number of intact neurons was 
152±2.0 in the sham group, 66±7.2 in the vehicle group, 126±6.0 in the UPF1 
preischaemic group, and 102±6.4 in the UPF1 reperfusion group (Figure 5).
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Figure 4. Photomicrographs of the hippocampal CAl region of rats, obtained from (A) the sham-operated, (B) the saline-treated, (C) the UPF1- 
treated 20 min before ischemia, and (D) the UPFl-treated immediately before reperfusion at x 1579 magnification (scale bar = 20 pm). Note no 
cell necrosis in (A), almost no intact pyramidal neurons in (B), and a few necroses (indicated by arrows) in a large number of intact pyramidal 
neurons in (C) and (D).
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Figure 5. The mean number of viable cells over the 1000 цт length of the CA1 layer. 
Vehicle — saline-treated rats; preischemic — UPF1-treated 20 min before ischemia; 
reperfusion — UPF1-treated immediately before reperfusion. Bars show S.E.M.
* P < 0.05 in comparison with the vehicle group.
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DISCUSSION
Paper I
Temporary cross-clamping of the abdominal aorta during aortic reconstructive 
surgery causes incomplete ischaemia of the lower limbs. This ischaemia is 
moderate in patients who undergo operations for occlusive aorto-iliac disease. 
Ischaemia is more severe in patients who undergo operation for elective AAAR 
or even ruptured AAAR (especially with normal peripheral circulation, e.g. 
without developed collateral circulation).
We found that lipid peroxidation (LP) indices (plasma DC and TBARS) did 
not reveal a statistically significant alteration during the perioperative period of 
AAAR. However, the highest value of TBARS was observed 5 min after the 
removal of the aortic cross-clamp. It is reported in the literature that changes in 
blood lipid peroxidation products have been detected during open-heart surgery 
involving cardiopulmonary bypass (Starkopf, Zilmer et al. 1995) and in a canine 
model of skeletal muscle ischaemia/reperfusion injury (Lindsay, Walker et al. 
1988). However, findings similar to those of our study have been described 
when measuring the specific marker of lipid peroxidation, F2-isoprostane, which 
remained unchanged in the perioperative course of elective AAA repair 
(Lindsay, Luo et al. 1999). Another study reported that the measured LP 
marker, lipid hydroperoxide (harvested from the radial arterial line), showed a 
significant sharp increase immediately on reperfusion in patients undergoing 
elective thoracoabdominal aortic aneurysm repair but not in patients undergoing 
elective AAA repair (Hafez, Berwanger et al. 2000).
Another marker of systemic OxS, serum TAC, reflects the potency of total 
antioxidative protection in plasma. We demonstrated that TAC decreased signi­
ficantly 30 min after the ischaemia of the lower limbs. In another study, Khaira 
et al observed that total antioxidant activity decreased significantly during the 
ischaemia of the lower torso and immediately after declamping of the abdo­
minal aorta in comparison with the preclamping levels in AAA resection and 
grafting (Khaira, Maxwell et al. 1996). It has to be emphasised that the marked 
decrease in TAC during the clamping of the abdominal aorta is an unexpected 
result before the generation of ROS during the reperfusion phase. It is probably 
caused by partial ischaemia resulting from the collateral supply of the lower 
torso and gastrointestinal organs during aortic clamping. Furthermore, Murphy 
et al have shown that antioxidant consumption occurs during aortic clamping 
whereas LP (the result o f ROS damage) is more marked during reperfusion 
(Murphy, Kolvenbach et al. 1992). Another study performed by Hafez et al 
showed a decrease in the levels of TAC immediately after reperfusion lasting up 
to 1 hour in patients treated for thoracoabdominal aortic aneurysm and 
abdominal aortic aneurysm (Hafez, Berwanger et al. 2000). Moreover, contro­
versial results were published by Brown et al who found no changes in the
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levels of TAC during AAAR; however, the samples were obtained from the 
femoral vein of only four patients (Brown, Dugdill et al. 1998).
To have a better understanding of the grade of OxS in AAAR, we also 
investigated the main indices of cellular OxS. We observed a statistically 
significant but relatively modest increase in the activity of the antioxidant 
enzymes CAT and GSHPx 30 min after the removal of the aortic cross-clamp. 
At the same time, we did not note changes in the antioxidative enzyme SOD 
during AAAR.
Moreover, the principal well-known intracellular marker of OxS, the 
glutathione redox status, was not significantly changed during the intraoperative 
period of AAAR. This fact speaks against cellular high-grade OxS. It has been 
reported by Pedrini et al that the muscular GSH/GSSG ratio decreased signifi­
cantly in the reperfusion phase after 3 hours of acute abdominal aortic balloon- 
catheter occlusion in sheep (Pedrini, Guamieri et al. 1993). These findings 
could be explained by severe ischaemia of the lower limbs, while it should be 
noted that a decrease was observed in the glutathione redox ratio in the skeletal 
muscle. Furthermore, Pedrini and the co-workers described a marked elevation 
of glutathione measured from the venous blood of an ischaemic site in patients 
suffering from acute lower limb ischaemia. Moreover, they observed a rapid 
increase of glutathione five minutes after the revascularisation of an acute 
ischaemic limb (Pedrini, Guamieri et al. 1993), (Pedrini 1999). It is worth 
noting that release of GSH from the ischaemic tissue should cause elevation of 
the levels of systemic GSH. Additionally, Sirsjo et al have reported depletion of 
skeletal muscle glutathione after severe hind limb ischaemia for 4 hours in rats 
during the reperfusion phase (Sirsjo, Kagedal et al. 1996).
Further, in a recent publication Westman et al have noted that the muscle 
level of reduced glutathione after AAAR was decreased, but there occurred no 
changes in the glutathione redox status. These results indicate that OxS elicited 
by elective AAAR is outbalanced by compensated GSH metabolism, not 
allowing increase oxidized GSH (Westman, Johansson et al. 2006), (Westman, 
Johansson et al. 2006).
It should be added that administration of heparin as a widely known agent with 
possible antioxidativity helps withstand ischaemia/reperfusion injury during this 
type of operations (Li, Cooley et al. 1995). Furthermore, regular administration of 
mannitol during elective AAA repair should be considered. Being a hyperosmolar 
sugar and a hydroxyl radical scavenger, mannitol is not a sufficiently strong 
antioxidant to act significantly in the human body (Oredsson, Plate et al. 1994). 
However, neither heparin nor mannitol influenced the OxS markers measured by 
us. Consequently, we eliminated theoretical considerations concerning administra­
tion of heparin and mannitol to solve the high grade of OxS or mimicking the 
moderate grade of OxS in patients during elective AAA resections.
Finally, we analysed and compared different subgroups (patients without 
collateral peripheral circulation/ patients with peripheral circulation) in our 
study group and found no statistically significant changes or alterations in the
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OxS markers during elective AAAR (data not shown). It should be noted that 
the patients’ number was not sufficient for valid comparison.
Paper III
Carotid endarterectomy for removing atherosclerotic plaque restores blood flow 
and reduces the incidence of ispilateral infarction (symptomatic and asympto­
matic carotid stenosis being >70%) (Rothwell and Warlow 1999), (Biller, 
Feinberg et al. 1998). At the same time, CAE itself possesses the risk for 
cerebral ischaemia and reperfusion injury.
We found changes in different markers of OxS, assessed from the peripheral 
arterial line, only during reperfusion (5 min after carotid clamp removal) in 
comparison with the preoperative values but not during ischaemia or later (at 
time point 30 min) during reperfusion.
A marker of lipid peroxidation, TBARS, showed the highest value 5 min 
after the beginning o f reperfusion. At the same time, another more specific 
marker of lipid peroxidation, DC, did not reveal statistically significant changes 
during CAE. Soong et al. have described an elevation of the malondialdehyde 
and diene conjugates obtained from the jugular vein after the removal of the 
Benner shunt and closure of arteriotomy with an average duration of 83 seconds 
(i.e. cross clamping time of the carotid artery) (Soong, Young et al. 1996). 
However, in comparing our data with those of the above study, it should be 
emphasized that we collected blood samples from the peripheral arterial line, 
while Soong et al obtained samples from the jugular vein. Further, a significant 
increase in malondialdehyde occurred during the reperfusion phase in patients 
who needed a temporary shunt during CAE (Weigand, Laipple et al. 1999).
A marker of systemic OxS, serum TAC, reflects the potency of total 
antioxidative protection of the plasma. According to the findings of our study, 
there occurred no changes in the level of TAC during CAE. Interesting findings 
were obtained by Weigand et al. who described a significant decrease in TAC 
during carotid artery clamping (and before shunt insertion) in patients with 
inadequate collateral blood flow (detected by somatosensory-evoked potentials 
as the extent of brain ischaemia during CAE). Furthermore, the above authors 
detected a higher baseline of TAC (measured from jugular venous-arterial 
blood) in patients who needed a temporary shunt during CAE (Weigand, Michel 
et al. 1999). Additionally, another study has reported a decrease in TAC after 
declamping of the carotid artery. We believe that the episode of ischaemia that 
occurred during CAE was not sufficiently severe or long to cause exhaustion of 
the potency of such an important system as total antioxidative capacity. Our 
findings did not show any significant changes in TAC during CAE probably 
because of the site o f blood sampling i.e. radial arterial line. Further, we 
understand that the antioxidative systems currently and mainly in the lungs may 
influence the results obtained by us.
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In order to better understand the grade of OxS during CAE, we also 
investigated the main markers of intracellular OxS. We detected a statistically 
significant but relatively modest increase in the activity of antioxidative 
enzymes, CAT and GSHPx, 5 min after the removal of the carotid artery clamp. 
However, there occurred no changes in the activity of the antioxidative enzyme 
SOD during CAE. Next, we established some elevated OxS in the peroxide 
level controlling system (e.g. CAT, GSHPx), which is interesting as the 
function of GSHPx is associated with the glutathione system. Moreover, we 
detected no changes in a well-known intracellular marker for OxS, the 
glutathione redox ratio, during this time-course study, while we observed a high 
level of the glutathione redox ratio at the first time point (preoperative value). In 
our previous studies we established the glutathione redox ratio from age- 
matched healthy volunteers and calculated the reference value that ranged from
0.13 to 0.3. We observed a significant difference between the reference value 
and the preoperative value of the glutathione redox ratio, which indicates a high 
level of intracellular OxS in these patients. It seems that any correction of the 
glutathione system using different manipulations (e.g. involving glutamine, N- 
Acetyl-L-cystein, etc) should be considered for these patients. Furthermore, we 
emphasise an interesting fact which might be correlated with the high values of 
the glutathione redox ratio for our study group. We established concomitant 
peripheral arterial disease in thirteen patients of 24. Recently, Lapenna et al. 
demonstrated that long-term depletion of GSH is associated with oxidative 
atherogenic effects (Lapenna, Pierdomenico et al. 2004). It is evident that 
further investigations should be performed to clarify the association of GSH 
depletion with PAD.
There are some limitations concerning this study. First, it is problematic to 
obtain fully reliable results using a relatively small number of patients as was 
the case with the present study. Despite this, we believe that the study might 
offer some interesting information about the time-course of OxS during CAE. 
Secondly, we did not perform transcranial Doppler or measured somatosensory- 
evoked potentials to detect the potential extent of brain ischaemia during CAE. 
Additionally, it should be noted that we measured the retrograde stump pressure 
of ICA (in cases where we suspected insufficient collaterals in the brain). And 
finally as in our study blood samples were only obtained from the peripheral 
artery, we emphasise that the changes that occurred in the OxS markers can not 
be interpreted organ-specifically.
Paper II
Powerful antioxidants as, e.g. carvelidol and its metabolite SB 211475, compro­
mise a methoxy group connected to the benzyl ring. To study the effect ot these 
moieties, we added a non-coded amino acid residue, 4-methoxy-phenylalanine, to
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the N-terminus of the GSH trimer to enhance antioxidativity, to increase 
hydrophobicity and to prolong the half-life of UPF1 in comparison with GSH in 
the organism. The UPF1 dissolves readily in water and even high concentrations 
of the peptide can be used in different in vitro and in vivo studies.
In the present study, UPF1 showed significantly higher antioxidativity com­
pared with GSH, measured by a THA dosimeter. Whether this 60-fold increase 
in antioxidativity (Figure 2) is caused by the methoxybenzyl group has to be 
studied further. Moreover, UPF1 did not show neurotoxicity in experiments 
with the primary cell cultures of cerebellar granule cells in the concentration 
range 0.01 to 100 цМ. However, it might be important to note, that as only three 
wells were used for each concentration, we suggest the existence of a non­
neurotoxicity trend of UPF1 in primary cell cultures.
As the glutathione analogue UPF1 showed high antioxidativity and a trend 
of non-toxicity in cell cultures, we performed animal experiments using a model 
of global brain ischaemia (i.e. four-vessel occlusion model). We demonstrated 
that administration of UPF1 (at a concentration of 0.9 mg/ml with a bolus dose) 
via the jugular vein, both before ischaemia and immediately before a reper­
fusion episode of global brain ischaemia, provides definite protection against 
ischaemia/reperfiision injury. The best treatment result was achieved when 
UPF1 was used 20 min before global brain ischaemia; however, this protector 
has also a significant effect when used immediately before reperfusion.
A model of forebrain transient global ischaemia in experimental animals is 
aimed to mimic human cerebral ischaemia due to transient cardiac arrest, or 
aortic arch reconstructive operations, or surgery of the extracranial arteries 
(including either various types of endarterectomies or/and bypass operations). In 
clinical practice, mainly during previously mentioned operations, it is possible 
to administer potential protective agents as UPF1 at the preischaemic time 
point. Additionally, such compounds can be administered during ischaemia, 
immediately before reperfusion and later during a reperfusion event. As 
transient cardiac arrest or stroke cannot be predicted, it is not possible to use 
pre-treatment strategies. Therefore, these cases can only be treated after an 
ischaemic event, e.g. stroke or transient cardiac arrest. Considering these 
clinical outcomes, we selected the first time point 20 minutes before ischaemia 
and then the time point immediately before a reperfusion event.
Moreover, induction of global cerebral ischaemia by a transient occlusion of 
the common carotid arteries or by a permanent occlusion of the vertebral 
arteries in rat causes delayed neuronal death in specific areas of the brain. 
Further, two to four days after transient global ischaemia, cell loss develops in 
the CA1 region of the hippocampus, evidently due to the damage caused by free 
oxygen radicals (Kitagawa, Matsumoto et al. 1990), (Kirino 1982).
We propose that UPF1 can be a promising lead compound for designing 
novel antioxidant drug precursors. However, up to now the exact mechanism of 
the action of UPF1 is not known. The UPF1 can act as a powerful free radical 
scavenger, or a modulator of G proteins in frontocortical membrane
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preparations (Karelson, Mahlapuu et al. 2002). Furthermore, one of the action 
mechanisms of UPF1 as a signal molecule can be associated with modulation of 
or increase in cellular GSH levels. Preliminary experiments have shown that 
basal GSH level increases about 20% in SH-SY5Y neuroblastoma cells after 
application of a 10 цМ UPF1 solution on the cells (our unpublished data). To 
study the mechanism of UPF1 more thoroughly, we have designed and 
synthesised a library of UPF1 analogues (26 different analogues). In the light of 
our data, we suggest that UPF1 may have a direct protective impact on oxygen 
free radicals -  acting as a scavenger, or acting as a signal molecule modulating 
the level of GSH itself or the GSH redox ratio.
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CONCLUSIONS ACCORDING TO THE PAPERS
Paper I
We demonstrated a decrease in TAC and an increase in the antioxidant enzymes 
CAT and GSHPx during the reperfusion phase. Neglecting the alterations in 
TAC, CAT and GSHPx and considering the almost unchangeable character of 
the other OxS parameters (e.g GSH), we conclude that the OxS observed at the 
systemic and cellular levels in patients undergoing AAA surgery is not high 
grade OxS and does not serve as a principal agent for ischaemia/reperfusion 
injury. Therefore, we suggest that routine administration of exogenous 
antioxidants is not an argument to be considered for elective AAA repair.
Paper III
We observed an increase in TBARS 5 min after carotid clamp removal; at the same 
time point the antioxidant enzymes CAT and GSHPx were elevated. Despite these 
moderate findings, we did not find occurrence of high grade OxS either in systemic 
or cellular level during CAE. The patients undergoing CAE showed a high baseline 
of the glutathione redox ratio. The latter phenomenon might support further 
investigation of the glutathione system with more focus on adjuvant therapy.
Paper П
In conclusion, the evidence presented in our study clearly suggests that UPF1 is 
a more powerful antioxidant agent compared with GSH in vitro , being also a 
non-neurotoxic and effective potential agent which diminishes neuronal injury 
in global cerebral ischaemia. Further research is required to increase the time 
window for using the glutathione analogue UPF1. Main interest should be 
directed to reperfusion injury protection management, e.g. to post-treatment 
strategy with the purpose to mimic a clinical situation after transient cardiac 
arrest or to possible treatment options after stroke.
General conclusions
1. High-grade OxS manifestation was not noted in patients during elective 
AAAR.
2. High-grade OxS manifestation was not found in patients during CAE.
3. High (i.e. abnormal) baseline of the glutathione redox ratio and simultaneous 
lack of cellular high-grade OxS in patients undergoing CAE as well as 
useless of administration of GSH itself lead to the necessity to investigate 
the effects of glutathione analogues during IRI.
4. The glutathione original analogue UPF1 showed a significant protective cha­
racter in a rat model of global brain ischaemia.
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SUMMARY IN ESTONIAN
Kliiniline ja eksperimentaalne uurimus: 
isheemia/reperfusiooni kahjustuse seos oksüdatiivse stressiga kõhuaordi 
aneurüsmi resektsioon-proteseerimisel ja ekstrakraniaalse ajuarteri 
endarterektoomial ning isheemia vastase kaitsevõimaluse uurimine 
glutatiooni analoogi UPF1 abil globaalse ajuisheemia mudelil rotil.
Isheemia ja  verevoolu taastamine ehk reperfusioon on aktuaalne teadusuurin­
gute valdkond. Viimase kolme aastakümnendi jooksul on süvenenud vastava- 
teemaliste kliiniliste ja  prekliiniliste uurimuste integratsioon. Need uurimused 
on tihti suunatud isheemia/reperfusiooni kahjustusele ja  nende tagajärgedele. 
Iga veresoontekirurg teab, et arteri klemmimise episood on vältimatu erinevate 
vaskulaarsete rekonstruktiivste operatsioonide puhul. Arteri klemmimine ja 
klemmi eemaldamine põhjustab vastavalt isheemia ja reperfusiooni. Selline 
tegevus on tehniliselt möödapääsmatu ruptureerunud ja elektiivse kõhuaordi 
aneurüsmi resektsioon-proteseerimisel ja unearteri endarterektoomial. Sügavast 
isheemiast ja sellele järgnevast reperfusioonist põhjustatud sügav oksüdatiivne 
stress tekitab olulisi kahjustusi ja sealhulgas düsfunktsiooni vöötlihastes, ajus jt. 
organites. Käesoleval ajal on laialdaselt aktsepteeritud seisukoht, et sügav 
oksüdatiivne stress mängib olulist rolli isheemia/reperfusiooni kahjustuse pato­
loogilises kaskaadis. Uuem teaduskiijandus sisaldab innovaatilist informat­
siooni oksüdatiivse stressi ja  isheemia/reperfusiooni kahjustuse kaitse võima­
lustest. Perspektiivikaks peetakse „glutatiooni süsteemi” uuringuid. Mõned 
glutatiooni prekursorid nagu N-atsetüültsüsteiin omavad kaitset isheemia/ 
reperfusiooni kahjustuse vastu nii südamelihases, maksas kui ka sooles. Samuti 
peetakse perspektiivseks glutatiooni analoogide kasutamist isheemia/reper­
fusiooni kahjustuse ja  sügava oksüdatiivse stressi korrigeerimiseks.
Käesolevas töös püstitati järgmised ülesanded:
-  Uurida oksüdatiivse stressi loomust (kas rakuline või süsteemne) ja  raskus­
astet (nõrk või sügav) elektiivse kõhuaordi aneurüsmi resektsioon-prote­
seerimisel
-  Uurida oksüdatiivse stressi loomust (kas rakuline või süsteemne) ja  raskus­
astet (nõrk või sügav) unearteri endarterektoomial
-  Selgitada glutatiooni analoogi UPF1 antioksüdatiivset loomust ja võimalikku 
neurotoksilisust ning testida UPF1 kaitsevõimet isheemia/reperfusiooni 
kahjustuse korral kasutades globaalse ajuisheemia mudelit rotil
Katsealusteks olid isikud, kellel teostati kõhuaordi aneurüsmi resektsioon-prote- 
seerimine ja unearteri endarterektoomia. Neurotoksilisuse katseteks kasutati 
hiire väikeaju granulaarrakkude primaarkultuure. Globaalse ajuisheemia katsed 
viidi läbi isastel Wistari liini rottidel.
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Põhijäreldused
Käesoleva uurimustöö kokkuvõtteks võib teha järgnevad järeldused:
-  Sügav oksüdatiivne stress perioperatiivselt ei kujune patsientidel, kellel 
teostati kõhuaordi aneurüsmi resektsioon-proteseerimine.
-  Sügavat oksüdatiivne stress perioperatiivselt ei kujune patsientidel, kellel 
teostati unearteri endarterektoomia.
-  Mitte-füsioloogiline (väga kõrge) glutatiooni redoks-suhte (GSSG/GSH) 
basaaltase ja samaaegne sügava rakulise oksüdatiivse stressi puudumine 
patsientidel, kellel teostati unearteri endarterektoomia ning glutatiooni enda 
kasutamisvõimaluse limiteeritus viitavad vajadusele uurida glutatiooni 
analoogide efektiivsust isheemia/reperfusiooni kahjustuse tingimustes.
-  Originaalne glutatiooni analoog UPF1 omas olulist kaitseefekti globaalse 
ajuisheemia mudelil rottidel.
Järeldused vastavalt publikatsioonidele
Artikkel I
Uuringu tulemusena selgus, et keskmiselt 60 minutilise alajäsemete isheemia 
tingimustes oli tõusnud CAT ja GSHPx väärtuste tase ajamomendil 30 minutit 
peale kõhuaordi klemmi eemaldamist võrreldes operatsioonieelsete väärtustega. 
Lisaks oli langenud üldise antioksüdatiivsuse näitaja markeri TAC’i väärtus 
võrreldes operatsioonieelse väärtusega. Nende tulemuste interpretatsioonil järel- 
dasime, et elektiivse kõhuaordi aneurüsmi operatsiooni korral ei tekki sügavat 
oksüdatiivset stressi ei rakulisel ega süsteemsel tasandil.
Eelnevast omakorda johtuvalt oli meiepoolne arvamus ja soovitus, et seda 
tüüpi operatsioonide korral pole tavaliselt manustatud mannitoolile ja  hepa- 
riinile lisaks vaja kasutada rutiinseid eksogeenseid antioksüdante.
Artikkel III
Uuringu tulemusena selgus, et 5 minutit peale unearterilt klemmi eemaldamist 
oli tõusnud TBARS’i väärtus võrreldes operatsioonieelse väärtusega. Samal 
ajamomendil olid ka antioksüdatiivsete ensüümide CAT ja GSHPx väärtused 
statistiliselt oluliselt kõrgemad võrreldes operatsioonieelsete väärtusega. Samas 
peab rõhutama fakti, et antud uuringugrupi patsientidel olid GSSG/GSH operat­
sioonieelsed väärtused tunduvalt kõrgenenud võrreldes GSSG/GSH väärtustega 
tervetel samaealistel vabatahtlikel. Sügavat süsteemset oksüdatiivset stressi ei 
tekkinud unearteri endarterektoomial.
Lisaks väidame, et GSSG/GSH kõrgenenud tase võib olla tingitud sama­
aegselt esinenud alajäsemete kroonilisest isheemiast (ehk alajäseme arterite 
oblitereeruvast ateroskleroosist), kuid see hüpotees vajab edasisi täpsustavaid 
uuringuid.
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Artikkel П
Uuringu tulemusena selgus, et UPF1 on oluliselt võimsam antioksüdant võrrel­
des GSH’ga in vitro, samuti pole UPF1 rakendavates kontsentratsioonides 
neurotoksiline. Glutatiooni analoog UPF1 osutus protektiivseks globaalse aju- 
isheemia kahjustuse korral.
Edasised uuringud peaksid tooma selgust UPF1 ajaliste kasutuspiiride kohta. 
Erilist tähelepanu peaks pöörama isheemiajärgsetele ravi võimalustele, jäljen­
dades kliinilist situatsiooni südame seiskumise ja vahetus ajuinfarkti järgses 
olukorras.
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ABSTRACT
Background and Aims: During elective abdominal aortic aneurysm repair (AAAR), low­
er torso ischaemia-reperfusion event is unavoidable. Previous studies on AAAR have 
reported the importance of oxidative stress (OS) in ischaemia-reperfusion injury, how­
ever, the grade of OS has not been adequately clarified up to now. The aim of this study 
was to perform a complex investigation of the time-course and grade of systemic and 
cellular OS in patients undergoing AAAR.
Material and Methods: Arterial blood samples were taken from 18 patients undergo­
ing elective AAAR (at four points in time: before anaesthesia, 5 min after aortic clamp­
ing and 5 min and 30 min after clamp removal). Diene conjugates (DC), thiobarbituric 
acid reactive substances (TBARS), total antioxidative capacity (TAC), glutathione redox 
ratio (GSSG/GSH), and levels o f antioxidative enzymes as superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GSHPx) were measured from the radial ar­
terial blood.
Results: 30 min after the removal of the aortic cross-clamp, arterial CAT showed sig­
nificant elevation (96.0 vs 56.9 U/l, p < 0.05); GSHPx was significantly elevated (51.5 vs 
39.9 U/g Hgb, p < 0.05) and TAC was decreased (31.4 vs 36.5 %, p < 0.05) in comparison 
with preoperative value.
Conclusions: We found limited alterations of several OS parameters, which do not 
characterize either systemic or cellular high-grade OS during elective AAAR.
Keywords: Abdominal aortic aneurysm repair; oxidative stress; ischaemia-reperfusion injury
INTRODUCTION AAAR depends on several factors including ischae­
mia-reperfusion (I/R) damage (1). During elective 
Abdominal aortic aneurysm (AAA) continues to re- AAAR, aortic clamp application (average time 1 hr) 
suit in significant morbidity and mortality. Even to- induces the lower torso I/R event. Simultaneously, 
day elective abdominal aortic aneurysm repair prolonged ischaemia, followed by reperfusion, can 
(AAAR) is an important challenge for vascular and result in I/R caused tissue/organ injury (2, 3). Dur- 
general surgeons. However, the positive outcome o f ing aortic cross clampings lack of oxygen leads to a
depletion o f the energy stores due to malproduction 
o f ATP via aerobic metabolism. Imbalance of the 
Correspondence energy requirem ents in the skeletal muscle tissue
P Põder M D causes leakage of the membrane, failure in Na-pump
Department of Vascular and Thoracic Surgery, function, and cellular excess of sodium and calcium,
University of Tartu resulting in cell edema. At the same time, excessive
Puusepa 8, Tartu 51014, Estonia production of reactive oxygen species (ROS) occurs,
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accompanied with elevated degradation of ATP, 
forming hypoxanthine. Normally, hypoxanthine is 
oxidized to xanthine by xanthine dehydrogenase, but 
in ischaemic conditions, at elevated cytosolic calci­
um, xanthine dehydrogenase is converted to xan­
thine oxidase (4, 5, 6). Unlike xanthine dehydroge­
nase, which uses NAD as a substrate, xanthine oxi­
dase uses oxygen. Therefore, the restoration of oxy­
gen supplementation during reperfusion leads to ex­
cessive production of oxygen free radicals by the xan­
thine/xanthine oxidase system, as well as by mito­
chondrial electron transport chain leakage and by 
activated neutrophils (7). Reactive oxygen species as 
superoxide, hydroxyl radical, hydrogen peroxide and 
hypochloric acid attack the biomembrane of polyun­
saturated fatty acids resulting in elevated lipid per­
oxidation.
The human body comprises an antioxidant net­
work, including enzymatic (e.g. superoxide dis- 
mutase and catalase) and nonenzymatic antioxidants 
(e.g. vitamin E and C), to withstand high grade dam­
age caused by OS. Furthermore, OS can be general­
ized (systemic) or cellular and its grade can be eval­
uated using different biochemical markers.
Today, despite the existence o f previous studies on 
AAAR, it is evident that there are yet unclear aspects 
(incomplete relevant data) o f the grade of OS during 
elective AAAR.
The aim o f this study was to evaluate the time- 
course nature of both systemic and cellular levels and 
grades of OS during elective AAAR by determining 
superoxide dismutase (SOD), catalase (CAT), glu­
tathione peroxidase (GSHPx), the glutathione redox 
ratio, total antioxidative activity and the lipid perox­
idation markers (diene conjugates and thiobarbituric 
acid reactive substances).
MATERIAL AND METHODS
The study was performed on 18 adults undergoing elec­
tive AAAR. The protocol used in this study was approved 
by the Ethics Committee o f  the University o f  Tartu. The 
main clinical characteristics are given in Table 1.
Presurgicai procedures were performed as follows: one 
hour before surgery, m o rp h in e  and dehydrobenzperidol
(Droperidol) were given intramuscularly for premedica­
tion. Arterial and Swan-Ganz pulmonary arterial catheters 
were inserted in all patients. Induction o f anesthesia was 
performed with atropine, etomidate and phentanyl. En­
dotracheal intubation was carried out with succinylcholinc. 
Muscle relaxation was achieved with pipecuronium and 
analgesia was performed with continuous infusion using 
fentanyl 3-4 ng/kg/h. The lungs were ventilated with iso­
flurane up to 1.5 vol. % with oxygen and N20. During AAA 
surgery, the central hemodynamic parameters were 
checked and measured with a Swan-Ganz catheter at three 
rime points: before surgical manipulation, after aortic cross 
clamping and at the end o f  the operation. At reperfusion, 
mannitol (0.5 g/kg) was administered regularly. We per­
formed elective AAAR as follows: a collagen impregnated 
woven prosthesis was inserted; the proximal anastomosis 
was done end-to-end to the abdominal aorta below the re­
nal arteries and the distal anastomoses were done end-to- 
side to the common femoral arteries or end-to-end to the 
common iliac arteries. Each patient received intravenous­
ly 3000 units o f heparin immediately before the cross 
clamping o f the abdominal aorta.
Samples were obtained from the peripheral arterial line 
(radial artery) at four rime points during elective AAAR 
(Table 2). Blood was harvested into 7-ml sterile lavender 
vacutainer tubes and was promptly transported to the lab­
oratory for analysis. The serum was separated by centrifu­
gation and kept in plastic tubes at -4 °C until analysis.
TABLE 1 Main clinical
characteristics o f  the study group.
Femae/male 3/15
Mean age, у 67.0, range 53-77
Abdominal aortic cross-clamping time (min) 61.3 ±3.9
Mean transversal diameteT o f abdominal
aortic aneurysm (cm) 7.8, range 5.8-9.7
Operating time (min) 229.6± 11.1
Smokers 5 of 18 (28 %)
Preoperatively existing diseases
PAD 10 of 18 (56%)
Hypertension 11 of 18 (61%)
Symptomatic myocardial ischemia 9 of 18 (50%)
Chronic respiratory disease 1 of 18 (6%)
Diabetes Oof 18(0%)
j*AD, peripheral arterial diseases
The diameter of AAA was determined preoperatively by Dop­
pler ultrasound measurement
TABLE2
Comparative dynamics o f  the systemic and cellular o f  OS indices during elective AAAR (n - 12-18).
Time points during AAAR A В С D
TBARS, nmol/ml 1.4 ±0.1 13±0.1 1.5 ±0.1 1.4 ±0.1
DC- umol/ml 24.1 ±1.3 23.7 ±1.5 24 0±1 4 911 ± 1 2
TAC, % 36.5 + 1.4* 352 ±13 33.5± 1.1 31.4±1.2
CAT,U/1 56.9 ±73* 63.7 ±4.6** 67.9 ±5.8 96.0 ±11.7
SOD. U/eHb 7192±35.1 648 4 + 414 670.9 ±343 7483 ±46.8
rS H P . II/oHh iq q ± ^ * 41 ?+ 4  s 467 +  SQ Sl S+4Q
GSSG/GSH 0.3 ±0.03 03 ±0.03 0.4 ±0.07 03  ±0.04
p < 0.05 for differences between the values of time points A and D 
p < 0.05 for differences between the values o f time points В and С
A.before induction of anaesthesia
B. 5 min after infrarenal abdominal aortic cross-clamping
C. 5 min after removal o f infrarenal abdominal aortic cross-clamp
D. 30 min after removal o f infrarenal abdominal aortic cross-clamp
208 P. Põder, A Pulges, J. Kals, A. Aavik, K. Zilmer, T. Kullisaar, C. Kairane, Ki. Zilmer
The following markers of systemic and cellular OS were 
measured: diene conjugates (DC), thiobaibituric acid reac­
tive substances (TBARS), serum total antioxidative capaci­
ty (TAC), glutathione redox status (the ratio of oxidized to 
reduced glutathione or GSSG/GSH), and the level of anti­
oxidative enzymes (superoxide dismutase, SOD, catalase, 
CAT and glutathione peroxidase, GSHPx). The methods or 
measurement of oxidative stress markers have been de­
scribed previously in detail. Briefly, TBARS were measured 
according to Ohkawa et al (8) with modifications (9). For 
the study of DC, the serum samples were incubated at 
37 °C for 25 min, the reaction was stopped by adding an 
antioxidant (butylated hydroxytoluene, BHT) ana the 
lipids were extracted. Thereafter the samples were spec- 
trophotometrically analysed at 233 nm (10). To correct the 
results for hemodilutabon, protein content in the samples 
was determined according to Lowry et al (11). To assess 
TAC, the ability of the serum to inhibit in vitro ünolenic 
acid peroxidation in the presence of 200 pmol/l Fe" was 
evaluated (12). SOD and GSHPx were measured accord­
ing to special protocols using commercially available kits 
(Randox Laboratories Ltd, Ardmore, UK) (13). CAT was 
measured using thiobaibituric acid reactive substances ac­
cording to the method described in literature (14). Total 
glutathione (TGSH) and CSSG as the parameters were 
measured by the enzymatic method of Tietze (15), which 
we slightly modified for the study (12). The content of GSH 
was calculated as the difference between the total amount 
of glutathione and GSSG (TGH-CSSG) All measurements 
of the lipid peroxidation products and the antioxidant 
markers were performed in triplicate within 4 h after blood 
sampling. The means were calculated and used for statis­
tical analysis. The haemolysed samples were excluded 
from analysis.
The data were analysed with the GraphPad Prism for 
Windows (version 3.0). For repeated measurments over die 
time-course of AAAR, the non-parametric Friedman test 
was used for comparison of the preoperative value with 
the values for the other time points, correcting multiple 
comparison with the Dunn test. The results are presented 
as the mean ± standard error of the mean (SEM) m the text 
and in the tables. The results were considered statistically 
significant if the P value was less than 0.05.
RESULTS
This study examined the time-course of the indices 
of systemic and cellular OS in 18 patients undergo­
ing elective AAAR. There were no complications as­
sociated with surgery, or death cases during the 
study period. Average perioperative blood loss was 
2033 ml and blood transfusion was 965 ml. The cell- 
saver was used during two abdominal aortic aneu­
rysm resections. However/two patients died during 
the postoperative course, one from recurrent myo­
cardial infarction and the other from multiple organ 
failure resulting from aspirated bilateral bronchop­
neumonia.
Arterial CAT revealed a significant elevation 
(96.0 ± 11.7) 30 min after aortic clamp removal in 
comparison with the preclamping value (56.9 ± 7.3) 
and 5 min after the application of the aortic cross­
clamp (63.7 ± 4.6). Simultaneously, changes were ob­
served in GSHPx 30 min after the removal of the ab­
dominal aortic clamp. The GSHPx was significantly 
elevated (51.51 %>) and TAC was decreased (31.4 %) 
in comparison with the corresponding value at the
preclamping time point. The markers of lipid perox­
idation, DC and TBARS, as well as the glutathione 
redox status and the antioxidant enzyme, SOD, did 
not show any significant changes during AAA sur­
gery (Table 2).
DISCUSSION
The following major findings were established in our 
study. The lipid peroxidation indices (plasma DC 
and TBARS) did not reveal statistically significant al­
teration. However, during the perioperative course 
the highest value of TBARS was observed 5 min af­
ter the removal of the aortic cross-clamp. It should 
be noted that changes in the blood lipid peroxida­
tion products have been detected during open-heart 
surgery for cardiopulmonary bypass (9) and in a ca­
nine model o f the skeletal muscle o f I/R injury (16). 
However, findings similar to those of our study have 
been described when measuring the specific marker, 
F2-isoprostane, which remained unchanged in the 
perioperative course of elective AAA surgery (2).
Another marker o f systemic OS, serum TAC, re­
flects the potency of total antioxidative protection in 
the plasma. Our observations demonstrated that TAC 
was significantly decreased 30 rain after the ischemia 
of the lower limbs. This information indicates the ex­
istence of a certain OS-based overload in the plasma 
during AAAR. In another study, Khaira et al ob­
served that total antioxidant activity decreased sig­
nificantly during the ischemia of the lower torso and 
immediately after aortic clamp removal in compari­
son with the preclamping levels in AAA resection 
and grafting (17). Controversial results were pub­
lished by Brown et al who found no changes in the 
levels of total antioxidant activity during AAAR; 
however the samples were obtained from femoral 
vein lines o f only four patients (18).
To have a better understanding of the gTade o f OS 
in AAAR, we also investigated the main indices of 
cellular OS. We detected a statistically significant, but 
relatively modest, increase in the activity of antioxi­
dative enzymes (CAT and GSHPx) 30 min after ab­
dominal aortic declamping. We did not reveal chang­
es in the antioxidative enzyme, SOD, during the op­
eration. Moreover, the principal well-known intrac­
ellular marker for OS, glutathione redox status, was 
not significantly changed during the intraoperative 
period o f AAAR. The latter fact also argues against 
cellular high-grade OS.
It should be added that administration o f heparin 
as a widely known agent with antioxidative proper­
ties helps to withstand ischaemia-reperfusion injury 
during this type of operations (19). Furthermore, reg­
ular administration o f mannitol during elective 
AAAR should be considered. Being a hyperosmolar 
sugar and a hydroxyl radical scavenger, mannitol is 
not a sufficiently strong antioxidant to act significant­
ly in the human body (20). However, at the same 
time, neither heparin nor mannitol influenced the OS 
markers measured by us. Consequently, we eliminat­
ed the theoretical considerations concerning admin­
istration o f  heparin and mannitol - solving the high
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grade o f OS or mimicking the moderate grade of OS 
in these patients during elective abdominal aortic 
aneurysm resections.
CONCLUSIONS
We demonstrated a decrease in TAC and an increase 
in the antioxidant enzymes CAT and GSHPx during 
a reperfusion event. Neglecting the alterations in 
TAC, CAT and GSHPx and considering the almost 
unchangeable character of the other OS parameters 
(e.g. GSH), we concluded that the OS observed at sys­
temic or cellular level in the patients undergoing 
AAA surgery was not high grade OS.
We therefore suggest that the routine administra­
tion o f  exogenous antioxidants is not an argument 
to be considered for elective AAAR.
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Abstract
Different glutathione analogues have potential to maintain or increase tissue glutathione level and to scavenge the reactive oxygen species. 
We designed and synthesized a novel non-toxic glutathione analogue, named UPF1, which possessed 60-fold higher hydroxyl radical scavenger 
efficiency in vitro, compared with glutathione itself, and investigated the effects of UPF1 on a four-vessel occlusion model of rats. The UPF1 
was administered via the jugular vein in two separate experiments at two time points: 20 min before global brain ischemia and immediately 
before reperfusion. In both cases the number of pyramidal cells surviving in the subfield ofC A l at the dorsal hippocampus in the UPF1-treated 
groups of rats was twice as high as in the vehicle group.
© 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: Four-vessel occlusion model; Global brain ischemia; Glutathione; Hippocampus; Antioxidant
Evidence has been accumulated over the last two decades sup­
porting the idea that reactive oxidative species (ROS) as hy­
droxyl radical, superoxide anion and hydrogen peroxide play 
a principal role in brain ischemia-reperfusion injury [5,7]. Si­
multaneously, it has been reported in several studies that glu­
tathione (GSH) depletion occurs during brain ischemia and 
reperfusion [1,4]. Furthermore, GSH is present in millimolar 
concentrations in most tissue cells including the brain. The 
GSH is known as an abundant non-protein thiol and a prin­
cipal provider of protection against damage by acting as a 
scavenger of ROS and as a substrate for glutathione peroxi­
dase [22]. The wide spectrum of the biofunctionality of GSH, 
including its crucial role in detoxification of electrophiles and 
in protection against oxidative or nitrosative stress, explains
* Corresponding author.
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the pharmaco-clinical strategies aimed at maintaining or in­
creasing tissue glutathione level.
The aims of the current study were to design and charac­
terize a novel glutathione analogue, named UPF1 (assignee 
Vulpes Ltd., no. 110035500, PCT/SE01/01351), and to in­
vestigate the effect of UPF1 in a rat model of global brain 
ischemia.
The glutathione analogue UPF1: 4-methoxy-L-tyrosinyl- 
7 -L-glutamyl-L-cysteinyI-glycine (4-MeO-Tyr--y-Glu-Cys- 
Gly; MW 483.5) was synthesized in accordance with the 
г-Boc-chemistry protocol as described in [16], or manually 
using Fmoc-chemistry [15]. The molecular mass o f the pep­
tide was determined by a MALDI-TOF mass spectrometer 
(Voyager DE-Pro, Applied Biosystem).
We tested the possible antioxidativity o f UPF1 to verify the 
hydroxyl radical scavenging effects, and also, we compared 
the antioxidativity of UPF1 to GSH. Briefly, we determined
18
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Fig. 1. Comparison of antioxidative potency of UPF1 (filled triangles) and 
GSH (empty squares).
the antioxidativity o f UPF1 as described by Barreto et al. 
[3], using terephthalic acid (THA) as the chemical dosimeter 
for hydroxyl radicals. The THA dosimeter solution contained 
10 nm THA in a 14.75 mM sodium phosphate buffer at pH 
7.5 and this buffer was used as the control. Hydroxyl radicals 
were generated via Fenton reaction by adding CUSO4 and 
H2O2 to the dosimeter solution in order to achieve the final 
concentration of 10 |xM and 1 mM, respectively. The effect 
of suppression of hydroxyl radicals was measured by a spec- 
trofluorometer (Perkin-Eimer LS5) at 312 nm excitation and 
at 426 nm emission [18]. The IC50 values were determined by 
sigmoid dose-response (viable slope) analysis (Fig. 1) with 
the GraphPad Prism version 3.0 (GraphPad Software Inc., 
San Diego, CA).
Further, we used primary cultures of cerebellar granule 
cells for the detection of the possible neurotoxicity of UPF1. 
The primary cultures of cerebellar granule cells were pre­
pared according to the method described by Gallo et al. with 
minor modifications 19]. Briefly, cerebelli were dissected 
from 8 -day-old Wistar rats and cells were dissociated by mild 
trypsinization followed by trituration in a 0.004% DNAse 
solution containing a 0.05% soybean trypsin inhibitor. The 
cells were resuspended in Basal Medium Eagle with Earle’s 
Salts containing 10% heat-inactivated foetal bovine serum, 
25 mM KC1, 2m M  glutamine and 100(xg/ml gentamycin. 
The cell suspension was seeded into 40 mm dishes precoated 
with 5 ц-g/ml of poly-L-lysine with a density of 1.3-1.4 x  
106 cells/ml. The cell cultures were grown for 8 days in hu­
midified 5% СОг/95% O2 atmosphere at 37 °C. After 24 h of 
incubation, 10 |xM cytosine-ß-arabino-furanoside was added 
to the culture medium to prevent the proliferation of non­
neuronal cells. Seven- or 8 -day-old cultures were used in the 
current experiment.
We treated each well with 2 |xl of either GSH (as the neg­
ative control) or UPF1, both mixed with 50 |xl of the medium 
at final concentrations of 0 .01 ,0 .1 ,10  and 100 (jlM. After 24 h 
of incubation, cell viability was assessed by a Trypan blue 
assay. The cultures were washed with phosphate buffered
saline and were then incubated with a 0.4% Trypan blue so­
lution at room temperature for 10 min. Only dead neurons 
were stained with Trypan blue [21]. The number of Trypan 
blue positive cells and viable non-stained cells was counted. 
Approximately 1000 cells per three fields in each well were 
counted to determine the viability of the cell cultures. For 
each concentration three wells were used. The viability of 
the cerebellar granular cells was presented as survival rate 
(e.g. the total number of the cerebellar granule cells minus 
the number of stained (dead) cells divided by the number of 
the cerebellar granule cells).
We performed animal experiments using a four-vessel oc­
clusion (4VO) model on rats. The experimental protocol for 
laboratory animals was approved by the Ethics Committee of 
the University of Tartu. Male Wistar rats weighing 270-350 g 
were used. The four-vessel occlusion model of forebrain is­
chemia, described by Pulsinelli and Brierly, was employed 
with some modifications [19,20]. Briefly, the rats were fasted 
overnight; anaesthesia was induced with 3% halothane in 
oxygen (at a rate of 0 .9 1/min), followed by orotracheal in­
tubation and the animals were respirated during the surgical 
procedure with a respirator (TSE Animal Respirator “Ad­
vanced”) [11]. A rectal temperature probe was inserted and 
body temperature was monitored and maintained at 37.0°C  
using a heating pad. First, the rats were mounted on a head 
holder and tilted downward by approximately 30°. The ver­
tebral arteries were coagulated through both alar foram ina’s 
of the first cervical vertebra. The bilateral common carotid 
arteries were exposed via a ventral midline incision and tran­
sient global forebrain ischemia was induced for 10  min by 
clamping both common carotid arteries with microvascu- 
lar clamps. During ischemia the animals were monitored for 
body temperature, respiration pattern, loss of righting reflex, 
unresponsiveness, corneal reflexes, as well as for fixed and 
dilated pupils. Restoration o f blood flow in the carotid ar­
teries was confirmed by careful visualisation. In the sham- 
operated group o f rats, both vertebral arteries were cauterised 
and both common carotid arteries were exposed but not 
clamped.
The animals were assigned randomly into one of the fol­
lowing groups: sham group; vehicle group of 4VO rats, which 
were given isotonic saline (up to 0.5 ml) into the external 
jugular vein; 4VO rats, which were given UPF1 into the exter­
nal jugular vein 2 0  min before inducing global brain ischemia 
(UPF1 preischemic); 4VO rats, which received UPF1 im­
mediately before reperfusion (UPF1 reperfusion). The UPF1 
was injected in a dose o f 0.9 mg/kg, dissolved in a saline so­
lution of up to 0.5 ml, into the jugular vein as a bolus dose 
during 30 s. This dose was selected proceeding from both the 
calculation derived from the measurements of the scavenging 
potency of UPF1, and from the analysis of some previously 
published reports [6,17].
Seventy-two hours following ischemia, the animals were 
killed by an intraperitoneal injection of fentanyl-fluanisone 
and midazolam for perfusion fixation of the brain with 
phosphate-buffered paraformaldehyde (4%) at pH 7.4 after
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Fig. 2. Low-power (4.5 x )  light micrograph of a 7 |xm coronal section stained by cresyl violet, showing the localisation of the counting frame at the middle 
part of the region of CA1. The size of the virtual frame was 0.4 mm x 1 mm and its major axis was along the pyramidal cell layer (scale bar = 1000 |im).
rinsing with 0.9% saline by cannulating the ascending aorta 
transcardially.
The representative coronal sections (7 |лт) of the dorsal 
hippocampus of the paraffin-embedded brains were sliced at 
200-|o.m intervals and were stained with cresyl violet. The 
number of surviving neurons in the CA1 area of the dorsal 
hippocampus was counted to quantify the extent of ischemic 
neuronal injury. To minimize bias in counting, all slices were 
assigned randomly and counted separately by three techni­
cians blinded to the experimental protocol. To standardize 
the counting procedures, a virtual frame lying at the mid­
dle portion of the dorsal hippocampus was used. The size 
of the virtual frame was 0.4 mm x 1 mm and its major axis 
proceeded along the pyramidal cell layer as in Bae et al. [2] 
(Fig. 2). All viable neurons within six frames in the left and 
right CA 1 regions of the three coronal sections o f the dorsal 
hippocampus for each animal were counted under the criteria 
proposed by Kirino [8 ] at 832-fold magnification using an im­
age analysis software package (AnalySIS 3.0; Soft Imaging 
System, Munster, Germany). Both sides of the dorsal hip­
pocampus were counted separately and the average number 
of viable pyramidal cells in each coronal section of the brain 
was selected as a representative value.
All experimental data are shown as mean ±  S.E.M. A 
normal distribution of the number of viable neurons was es­
tablished using the Shapiro-Wilk test (P > 0.05). The mean 
number of viable pyramidal cells in the UPF1 -treated groups
was compared with the number of viable pyramidal cells in 
the vehicle-treated group by one-way ANOVA test with the 
Dunnett correction using the statistical program GraphPad 
Prism version 3.0. A value of P < 0.05 was considered to 
indicate statistical significance.
We found that UPF1 possesses a clear hydroxyl radical 
scavenging nature in vitro. Enhancement of hydrophobic 
moiety with attached methoxy group to the N-terminus of 
GSH increased dramatically antioxidative properties of pep­
tide. The IC50 of UPF1 (20.5 ±  2.3 (jlM ) was about 60 times 
lower compared with the corresponding value of GSH (IC50 
= 1254.1 ±  382.2 ^M) (Fig. 1).
The viability of the cerebellar granule cells treated with 
UPF1 (ranging from 90 to 87%) was similar to that of the non­
treated (ranging from 91 to 90%) and GSH-treated controls 
(ranging from 92 to 90%) at each concentration used (even at 
the concentration of 100  |xM survival was similar to that for 
the control group, Fig. 3). We suggest that the current results 
indicate a beneficial, i.e. non-toxic, trend of UPF1 in primary 
cultures.
Sixty-three rats were used in the animal experiments; 24 
animals died; 16 rats, which remained unresponsive through­
out the ischemic period, or whose temperature dropped be­
low 36.0 °C, or which developed epileptic seizures, or which 
required persistent assisted pulmonary ventilation postoper- 
atively, were excluded from the study. Five rats in the sham 
group, eight rats in the vehicle group, five rats in the UPF1
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Fig. 3. Survival of the cerebellar granular cells at different concentrations 
of UPF1. Control: untreated cells.
preischemic group, and five rats in the UPF1 reperfusion 
group completed the study.
The representative sections obtained 72 h after ischemia 
and stained with cresyl violet are shown in Fig. 4. The number 
of intact neurons was 152 ±  2.0 in the sham group, 66 ±  7.2 in
the vehicle group, 126 ±  6.0 in the UPF1 preischemic group, 
and 102 ±  6.4 in the UPF1 reperfusion group (Fig. 5).
Powerful antioxidants as, e.g. carvelidol and its metabolite 
SB 211475, compromise a methoxy group connected to the 
benzyl ring. To study the effect o f these moieties, we added 
a non-coded amino acid residue, 4-methoxy-phenylalanine, 
to the N-terminus of the GSH trimer to enhance antioxida- 
tivity, to increase hydrophobicity and to prolong the half- 
life of UPF1 in comparison with GSH in the organism. The 
UPF1 dissolves readily in water and even high concentrations 
of the peptide can be used in different in vitro and in vivo 
studies.
In the present study UPF1 showed significantly higher 
antioxidativity compared with GSH, measured by a THA 
dosimeter. Whether this 60-fold increase in antioxidativity 
(Fig. 1) is caused by the methoxybenzyl group has to be 
studied further. Moreover, UPF1 did not show neurotoxicity 
in the experiments with the primary cell cultures of cerebellar 
granule cells in the concentration range 0 .01-100 jjlM. How­
ever, it might be important to emphasize as only three wells
Fig. 4. Photomicrographs of the hippocampal CA1 region of rats, obtained from (A) the sham-operated, (B) the saline-treated. (C) the UPFl-treated 20min 
before ischemia, and (D) the UPFl-treated immediately before reperfusion at 1579x magnification (scale bar = 20 p.m). Note no cell necrosis in (A), almost 
no intact pyramidal neurons in (B), and a few necroses (indicated by arrows) in a large number of intact pyramidal neurons in (C) and (D).
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Fig. 5. The mean number of viable cells over the 1000 jim length of the CA1 
layer. Vehicle: salinc-treated rats; рте ischemic: UPFl-treated 20 min before 
ischemia; reperfusion: UPF1-treated immediately before reperfusion. Bars 
show S.E.M. "P < 0.05 in comparison with the vehicle group.
were used for each concentration, we suggest the existence of 
a non-neurotoxicity trend of UPF1 in primary cell cultures.
As the glutathione analogue UPF1 showed high an­
tioxidativity and a trend o f non-toxicity in cell cultures, 
we performed animal experiments using a global brain is­
chemia model (i.e. four-vessel occlusion model). We demon­
strated that the administration of UPF1 (at a concentration of 
0.9 mg/ml with a bolus dose) via the jugular vein, both be­
fore ischemia and immediately before a reperfusion episode 
of global brain ischemia, provides definite protection against 
ischemia/reperfusion injury. The best treatment result was 
achieved when UPF1 was used 20 min before global brain 
ischemia; however, this protector has also a significant effect 
when used immediately before reperfusion.
Moreover, it has to be emphasized that in our animal ex­
periments (20 min of global brain ischemia) general mortality 
rate was 38% (the lowest in the UPF1 reperfusion group and 
the highest in the vehicle group, 11 and 45%. respectively). 
In studies performed by Herguido et al., mortality rate for 
10 min global brain ischemia was 29% in the perioperative 
period and 29% in the postoperative period Г10]. Hence, pro­
ceeding from the data of above study, the mortality rate in 
our study can be considered admissible.
A model o f forebrain transient global ischemia in experi­
mental animals is aimed to mimic human cerebral ischemia 
due to transient cardiac arrest, or aortic arch reconstructive 
operations, or surgery o f the extracranial arteries (including 
either various types o f endarterectomies or/and bypass oper­
ations). In clinical practice, mainly during previously men­
tioned operations, it is possible to administer potential pro­
tective agents as UPF1 at the preischemic time point. Ad­
ditionally, such compounds can be administered during is­
chemia, immediately before reperfusion and later during a 
reperfusion event. As the transient cardiac arrest or stroke 
cannot be predicted, it is not possible to use pre-treatment 
strategies. Therefore, these cases can only be treated after 
ischemic event, e.g. stroke or transient cardiac arrest. Con­
sidering these clinical outcomes, we selected first time point
20 min before ischemia and then the time point immediately 
before reperfusion event
Moreover, induction o f global cerebral ischemia by a tran­
sient occlusion of the common carotid arteries or by a per­
manent occlusion of the vertebral arteries in the rat causes 
delayed neuronal death in specific areas of the brain. Further, 
2 to 4 days after transient global ischemia, cell loss develops 
in the CA1 region of the hippocampus, evidently due to the 
damage caused by free oxygen radicals [13,14].
We propose that UPF1 can be a promising leading com­
pound for designing novel antioxidant drug precursors. How­
ever, up to now the exact mechanism of the action o f UPF1 
is not known. The UPF1 can act as a powerful free radical 
scavenger, or a modulator o f the C» proteins in frontocortical 
membrane preparations f 12J. Furthermore, one o f the action 
mechanisms of UPF1 as a signal molecule can be associ­
ated with modulation of or increase in cellular GSH levels. 
Preliminary experiments have shown that basal GSH level 
increases about 20% in the SH-SY5Y neuroblastoma cells 
after application o f a 10 jjlM UPF1 solution on the cells (our 
unpublished data). To study the mechanism of UPF1 more 
thoroughly, we have designed and synthesised a library of 
UPF1 analogues (26 different analogues). In the light of our 
data, we suggest that UPF1 may have a direct protective im­
pact on oxygen free radicals— acting as a scavenger, or acting 
as a signal molecule modulating the level of GSH itself or the 
GSH redox ratio.
In conclusion, the evidence presented in our study clearly 
suggests that UPF1 is an effective potential agent diminish­
ing neuronal injury in global cerebral ischemia. Further stud­
ies are required to increase the time window for using the 
glutathione analogue, UPF1. Moreover, main interest would 
be the reperfusion injury protection management, e.g. post­
treatment strategy with the purpose to mimic a clinical situa­
tion after transient cardiac arTest or possible treatment options 
after stroke.
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Цель: Головной мозг особенно уязвим перед трав­
мой, вызванной свободными радикалами кислорода. 
Ишемически-реперфузионное повреждение после 
церебральной ишемии связывают с окислительным 
стрессом. В работе изучалась временная динамика 
и интенсивность окислительного стресса (ОС) на 
системном и клеточном уровнях при проведении 
каротидной эндартерэктомии (КЭАЭ).
Материал и методы: Были взяты пробы крови 
24 пациентов во время КЭАЭ (в четырех временных 
точках: перед анестезией, через 5минут после пере­
жатия сонной артерии, через 5 и 30 минут после 
удаления зажима с каротидной артерии). Измеряли 
содержание диеновых конъюгатов (DC), реактивных 
соединений тиобарбитуровой кислоты (TBARS), 
общую окислительную активность (0 0 А), глутати- 
оновый окислительно-восстановительный статус 
(GSSH/GSH) и уровень антиоксидантных ферментов, 
таких как супероксиддисмутаза (СОД), каталаза 
(КАТ) и глутатионовая пероксидаза (GSHPx).
Результаты: Через 5 минут после удаления 
каротидного зажима наблюдалось достоверное 
повышение уровня ТВ A RS (1,7 против 1,5 нмоль/л, 
р<0,05) и КАТ (89,0 против 64,5ед/л,р<0,05). В той 
же временной точке достоверно повышалось содер­
жание GSHPx (38,2 против 37,5 ед/гНЬ, р<0,05) по 
сравнению с предоперационными значениями.
Выводы: Во время КЭАЭ окислительный стресс 
не достигает высокого уровня, как на системном, 
так и на клеточном уровнях, за исключением уме­
ренных изменений различных маркеров ОС.
К лю чевы е слова: ишемически-реперфузионное по­
вреждение, окислительный стресс, каротидная эн- 
дартерэктомия, глутатион, общая окислительная 
перекисное окисление липидов.
ВВЕДЕНИЕ 
П р о ц ед у р а  к а р о т и д н о й  эн д а р те р эк то м и и  
(КЭАЭ) сопряж ена непродолж ительным эпизодом 
локальной церебральной иш емии с последующей 
р еперф узией . Х орош о и звестн о , что головной
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Purpose: The brain is at special risk from oxygen free 
radical mediated injury. Oxidative stress (OxS) has been 
implicated in cerebral ischemia-reperfusion injury. Study 
was devised to investigate the time-course nature o f both 
systemic and cellular levels and grades of oxidative stress 
during carotid endarterectomy (CAE).
Material and Methods: Arterial blood samples were 
taken from 24patients undergoing CAE (at four time points: 
before anaesthesia, 5 min after carotid artery clamping, 5 min 
and 30 min after the removal of the carotid artery clamp). 
Diene conjugates (DC), thiobarbituric acid reactive substances 
(TBARS), total antioxidative capacity (TAC), glutathione 
redox ratio (GSSG/GSH), and levels of antioxidative en­
zymes as superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GSHPx) were measured.
Results: 5 min after the removal of the carotid clamp, 
TBARS showed a significant elevation (1.7 vs 1.5 nmol/1, 
p<0.05), CAT was significantly elevated (89.0 vs 64.5 
U/l, p< 0.05) and at the same time point GSHPx was 
significantly increased (38.2 v.s 37.5 U/gHb, p<0.05) in 
comparison with the preoperative values.
Conclusions: During CAE no high grade OxS oc­
curred either at systemic or cellular level measured from 
peripheral artery, besides moderate changes in different 
OxS markers.
K ey words: ischemia-reperfusion injury; oxidative stress; 
carotid artery endarterectomy ; glutathione; total antioxida­
tive capacity; lipid peroxidation.
INTRODUCTION
Carotid artery endarterectomy presents a discrete 
episode of focal cerebral ischemia followed by reperfusion. 
It is well known that the brain is at high risk from oxygen 
free radical mediated injury because of its larger iron stores, 
high levels of polyunsaturated 1 ipids and limited antioxidant 
defences 11]. Consequently, oxidative stress (OxS) has been 
implicated in cerebral ischemia-reperfusion injury [2] and 
such injury in animal models has been shown to be prevent­
ed or ameliorated by an adequate and sufficient antioxidant 
therapy [3, 4]. At present, despite previous studies on the 
products of lipid peroxidation (e.g. malondialdehyde, diene
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мозг подвержен высокому риску поражения, опо­
средованного свободными радикалами кислорода, 
из-за больших запасов железа, высокого уровня по- 
линенасыщ енных липидов и ограниченной актив­
ности антиоксидантной зашиты [1]. В результате, 
считается, что окислительный стресс (ОС) является 
причиной церебральной иш емически-реперфузи- 
онного повреждения [2]. На экспериментальных 
моделях на ж ивотны х было показано, что такое 
повреждение можно предотвратить или ослабить 
адекватной антиоксидантной терапией [3, 4]. До 
настоящ его времени, помимо некоторых работ о 
содерж ании продуктов перекисного окисления 
липидов (например, малонового диальдегида и ди­
еновых коньюгатов), нет достаточной информации 
о глубине и динамике ОС на системном и клеточном 
уровнях при проведении КЭАЭ. Выраженность ОС 
(генерализованный/системный или клеточный) и 
его интенсивность можно оценить с помощью раз­
личных биохимических маркеров. Более того, чело­
веческий организм и меет систему антиоксидантной 
защиты, в которой участвуют ферментные (напри­
мер, супероксиддисмутаза, каталаза и глутатионовая 
пероксидаза) и неферментные (например, витамины 
Е и С) антиоксиданты. Они позволяют защ итить 
организм от сильного ОС. В физиологических усло­
виях свободные радикалы нейтрализуются эндоген­
ными антиоксидантами и гасителями свободных 
радикалов, однако когда эти защитные механизмы 
иссякают, в окружающих тканях может развиться 
повреждение [5]. Цель данной работы состояла в 
изучении временной динамики ОС на системном и 
клеточном уровнях и интенсивности О Снаорганиз- 
менном уровне при проведении КЭАЭ.
МАТЕРИАЛЫ И МЕТОДЫ 
Исследование выполнено на 24 взрослых паци­
ентах, перенесших КЭАЭ. Протокол исследования 
был одобрен Комиссией по этике Университета 
Тарту. О сновны е кли н и чески е  характеристики  
пациентов приведены в табл. 1.
2.1. Анестезия
После премедикации м ид азоламом (F. Hoffman — 
La R oche, Ш в ей ц ар и я) п р о во ди л и  анестези ю  
атропином (Nycomed Pharma Holding AS, Дания), 
этомидатом (В. Braun Melsungen AG, Германия) и 
ф ентанилом (Gedeon Richter, Словакия).
Э ндотрахеальную  интубацию  проводили под 
с у к ц и н и л х о л и н о м  (G laxoS m ithK line, В ел и к о ­
бри тания). М ы ш ечная релаксация достигалась 
пиперкурониум ом  (Gedeon Richter, С ловакия), а 
ан ал ьгези я  — непрерывной инфузией фентани- 
ла (3 -4  ц/кг/час). Газовая смесь для вентиляции 
легких содержала изофлуран (Halocarbon Products 
Corp. США) до 1,5 объемных процентов, кислород и
conjugates), the information on the grade of OxS and on 
the changes occurring on the systemic and cellular levels 
of OxS during carotid artery endarterectomy (CAE) is 
still limited. The expression of OxS (generalised/systemic 
or cellular) and the grade of OxS can be evaluated using 
different biochemical markers. Furthermore, the human 
body comprises an antioxidant network including enzy­
matic (e.g. superoxide dismutase, catalase and glutathione 
peroxidase) and nonenzymatic antioxidants (e.g. vitamin 
E and vitamin C), to withstand excessive damage caused 
by high-grade OxS. Under physiological conditions, free 
radicals are neutralised by the presence of endogenous 
antioxidants and free radical scavengers, however, when 
these protective mechanisms are overwhelmed, injury of 
the surrounding tissues may occur [5].
The purpose of this study was to investigate the time- 
course nature of both, systemic and cellular levels of OxS 
and grades of OxS during the carotid endarterectomy on 
the organism level.
MATERIAL AND METHODS 
The study was performed on 24 adults undergoing 
elective carotid endarterectomy. The protocol used in 
this study was approved by the Ethics Committee of the 
University ofTartu. The main clinical characteristics are 
given in Table 1.
2 .1. Anaesthesia
After premedication with midazolam (F. Hoffmann- 
La Roche, Switzerland), anaesthesia was induced with 
atropine (Nycomed Pharm a Holding AS, Denmark), 
etom idate (B. Braun M elsungen AG, Germany) and 
fentanyl (Gedeon Richter, Slovakia). Endothracheal 
intubation was carried out with succinylcholine (Glaxo 
Smith Kline, UK). Muscle relaxation was achieved with 
pipercuronium (Gedeon Richter, Slovakia) and analgesia 
was performed with continuous infusion using fentanyl 
3 - 4  |Vkg/h. The lungs were ventilated with isoflurane 
(Halocarbon Products Corp., SC, USA) up to 1.5 vol. 
% with oxygen and N 20 . All patients were mechanically 
ventilated to maintain normocapnia with P aC 02 of 38 
to 41 mmHg. In all patients an arterial catheter was 
inserted, ECG, end-tidal capnometry, and changes in 
arterial blood pressure were continuously recorded. A 
neurological examination was performed immediately 
after the patient awakened, 1 hour later, and then daily 
until the patient was discharged. During carotid surgery, 
we did not use transcranial Doppler ultrasound, or the 
monitoring of somatosensory evoked potentials, or elec­
troencephalography. Each patient received 3000 units of 
heparin (Leo Pharmaceutical Products, Denmark) before 
the cross clamping. During the endarterectomy blood 
pressure was raised and maintained pharmacologically (at 
least 20 mmHg) with phenylephrine (Sanofi Winthrop, 
New York, NY, USA) in each patient above individual 
blood baseline pressure values.
112
П.Подер и др.: Динамика окислительного стресса
при выполнении каротидной эндартерэктомии
Таблица 1/Table 1
О с н о в н ы е  к л и н и ч е с к и е  х а р а к т е р и с т и к и  груп п ы  п а ц и е н то в  
M ain  clin ic a l  c h a r a c ter istic s  o f  th e  s tu d y  g ro u p
Пол (ж/м)
Средний возраст, лет (интервал)
«-г гг. '■*
Время пережатия сонной артерии, мин.
Стандартная эндартерэктомия /эверсионная эндартерэктомия
■ sïïà ïS ïZ  '  ‘ " - ........  “  "  .............. “ -  ‘ **
Показания к каротидной эндартерэктомии:
5/19
68.0 
range (44-84)
18 + 1,1 
13/11
Симптоматический стеноз сонной артерии 60-70%  (тромбоэмбологенные бляшки)*Й9ЙЙ*
Симптоматический стеноз сонной артерии >70%
Предшествующие и сопутствующие заболевания:
Заболевание периферических артерий
6 из 24 (25%)
18 из 24 (75%)
13 из 24 (54%)
10 из 24 (42%)
Заболевание коронарных сосудов
г -■ ■ ■у-/: ■?ase - _______  у .
3 из 24(13%)
Диабет
Diabetes _________  - -
1 из 24 (4%)
* — по данным допплерографии
* — Detected by Doppler ultrasound
N 20. Д ля  всех пациентов применяли искусственную 
вентиляцию легкихдля поддержания нормокапнии 
с РаС 02 от 38 до 41 мм рт.ст. Всем вводили артери­
альный катетер, непрерывно регистрировали ЭКГ, 
АД и проводили капнометрию  на конце выдоха. 
Неврологическое обследование осущ ествлялось 
сразу после того, как пациент приходил в себя, еще 
через час и затем ежедневно до выписки пациента 
из стационара. Во время КЭАЭ мы не использовали 
транскраниал ьную допплерографию, регистраци ю 
соматосенсорны х вы званны х потенциалов или 
электроэнцефалографию. Каждому пациенту вво­
дил и 3 ООО ед. гепарина (Leo Pharmaceutical Products, 
Дания) перед пережатием сонной артерии. Во время 
эндартерэктомии у каж дого пациента вызывали 
подъем АД не менее, чем на 20 мм рт.ст. относительно 
исходного уровня, и удерживали повышенное АД с 
п о м о щ ь ю  фенилэф рина (Sanofi Withthrop, США).
2.2. Взятие проб крови
Пробы крови отбирали катетером из перифе- 
ж ческой артерии (лучевой) четырежды, вопреде-
2.2 Blood sampling
Blood samples were collected regularly from the pe­
ripheral arterial line (the radial artery) at four time points 
(before anaesthesia, 5 min after carotid artery clamping, 
5 min and 30 min after the declamping) during CAE. The 
blood was taken into 7-ml sterile lavender vacutainer tubes 
and promptly transported to the laboratory for analysis. 
The serum was separated by centrifugation and kfept in 
plastic tubes at -20°C until analysis.
2.3. Measurement of oxidative stress markers
Several markers of systemic and cellular OxS were 
measured, as diene conjugates (DC), thiobarbituric acid 
reactive substances (TBARS), serum total antioxida­
tive capacity (TAC), glutathione redox status (the ratio 
of oxidized to reduced glutathione or G SSG /G SH ), 
and the level of antioxidative enzymes — superoxide 
dismutase (SOD), catalase (CAT) and glutathione per­
oxidase (GSHPx). The methods of measurement of the 
OxS markers have been described in detail previously. 
Briefly, TBARS were measured according to Ohkawaet 
al. [6] with modifications [7]. For the study of DC, the
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ленное время — перед анестезией, через 5 минут 
после пережатия сонной артерии, через 5 и 30 ми­
нут после удаления зажима с каротидной артерии. 
Кровь отбирали в стерильные пробирки lavender 
vacutainer объемом в 7 мл и экстренно направля­
ли в лабораторию  для анализа. Плазму отделяли 
центрифугированием и содержали в пластиковых 
пробирках при -20°С до проведения анализа.
2.3. Измерение маркеров окислительного стресса
Проводили измерение нескольких маркеров
системного и клеточного ОС: диеновых коньюгатов 
(DC), реактивны х соединений тиобарбитуровой 
кислоты (TBARS), общую окислительную  актив ­
ность плазмы (ООА), глутатионовый окислительно­
восстановительный статус (отношение окисленной 
формы глутатиона [GSSG J к восстановленной фор­
ме [GSHJ) и уровень антиоксидантных ферментов — 
супероксиддисм утазы  (СОД), каталазы  (КАТ) и 
глутатионовой пероксидазы  (GSHPx). Методы из­
мерения маркеров ОС подробно описаны в опубли­
кованных ранее работах. Вкратце, ТВА RS измеряли 
по методу Ohkawa et al. [6] в модификации |7 |. Для 
измерения DC пробы плазмы инкубировали при 
37°С в течение 25 минут, затем реакцию  останав­
ливали  добавлением  антиоксиданта (бутилиро- 
ванного гидрокситолуена — БГТ) с последующей 
экстракцией липидов. Затем проводили спектро­
фотом етрический анализ проб при 233 нм [8]. Для 
поправки результатов на гемодилюцию определяли 
содержание белка в пробах по методу Lowry et al.
[9]. Для оценки ООА измеряли способность плазмы 
ингибировать in vitro перекисное окисление лино- 
леновой кислоты  в присутствии 200 цмоль/л Fe+2
[10]. СОД и GSHPx измеряли по специальному про­
токолу с использованием коммерческих наборов 
(Randox Laboratories Ltd, В еликобритания). КАТ 
измеряли с помощью реактивны х веществ тиобар­
битуровой кислоты по описанному ранее методу 
(12]. Содержание общего глутатиона (TGSH) и его 
окисленной формы (GSSG) измеряли ферментным 
методом Tietze [13], несколько модифицированным 
для наш его исследования [10]. Содержание вос­
становленной формы глутатиона (GSH) вычисляли 
как  разницу между общ им и окисленны м  глутати- 
оном (TGSH — GSSG). Все измерения продуктов 
перекисного окисления липидов и маркеров ОС 
проводили в трех повторах в течение 4 часов после 
взятия крови. Гемолизированные пробы из анализа 
исклю чались.
2.4. Статистический анализ
Регистрацию  данны е и статистический анализ 
проводили с помощью программного обеспечения 
G raphPad Prism 3,0 (GraphPad Software Inc., С ан- 
Диего, CILIA). Д ля сравнения предоперационных 
зн ач ен и й  пар ам етр о в  со зн ач ен и ям и  в других
serum samples were incubated at 37°C for 25 min, the 
reaction was stopped by adding an antioxidant (butylated 
hydroxytoluene, BHT) and the lipids were extracted. 
Thereafter the sam ples were spectrophotom etrically 
analysed at 233 nm  [8]. To correct the results for hemo- 
dilution, protein content in the samples was determined 
according to Lowry et al. [9[. To assess TAC, the ability 
ofthe serum to inhibit in vitro linolenic acid peroxidation 
in the presence of 200 цто1/1 Fe2+ was evaluated [10]. 
SOD and GSHPx were measured according to special 
protocols using commercially available kits (Randox 
Laboratories Ltd, Ardmore, UK) [11]. CAT was mea­
sured using thiobarbituric acid reactive substances ac­
cording to the method described in literature [12]. Total 
glutathione (TGSH) and GSSG as the parameters were 
measu red by the enzymatic method of Tietze [13], which 
was slightly modified for the present study [10]. The con­
tent of GSH was calculated as the difference between the 
total amount of glutathione and GSSG (TGH-GSSG). 
All measurements of the lipid peroxidation products and 
the antioxidant markers were performed in triplicate 
within 4 h after blood sampling. The haemolysed samples 
were excluded from analysis.
2.4. Statistical analysis
The data were recorded and used for statistical 
analysis with the GraphPad Prism version 3.0 (GraphPad 
Software Inc., San Diego, CA). For repeated measure­
m ents over the tim e course o f elective carotid artery 
endarterectomy, the non-param etric Friedman test was 
used for comparison of the preoperative value with the 
values for the other tim e points, correcting multiple 
comparison with the Dun n test. The results are presented 
as the mean ± standard error of the mean (SEM) in the 
text and in the tables. The limit of statistical significance 
P value was at 0.05.
RESULTS
The tim e-course of the indices of systemic and cel­
lular OxS was studied in 24 patients undergoing elective 
CAE. There were no fatal com plications associated 
with surgery. However, two patients had postoperative 
perm anent neurological deficit. One patient became 
hemiparetic and the other patient had apalic syndrome. 
Both patients had had cerebral infraction preoperatively, 
which had been identified with CT and these patients had 
minor neurological deficit before surgery. The indications 
for CAE are shown in Table 1. No vascular shunt was 
used during CAE. Seventeen patients of 24 took aspirin 
(Lannacher, Austria) as antiplatelet medication, whereas 
none of the patients took antioxidants. Arterial TBARS 
revealed a statistically significant increase (1.7 ±0.1) 5 
min after carotid clamp removal in comparison with the 
preclamping value (1.5 ± 0.1). At the same time, an eleva­
tion in CAT and GSHPx (89 ± 9 and 38 ±  3, respectively) 
was observed 5 min after the declamping in comparison
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временных точках применяли непараметрический 
критерий Ф ридм ана, с поправкой на многократ­
ные сравнения с помощ ью  теста Д анна. В тексте 
и табли це результаты  п р едставлен ы  как сред­
нее ± стандартная ош ибка. Уровень статистической 
достоверности установлен на 0,05.
РЕЗУЛЬТАТЫ 
Временная ди нам и ка показателей системного 
и клеточ ного ОС изучена на 24 пациентах, перенес- 
ших КЭАЭ. Не было зарегистрировано ни одного 
летального ослож нения операции. Однако у двух 
пациентов после операции развился стойкий не- - 
врологический деф ицит — у одного гемипарез, у 
другого апали ческий  синдром . Оба пациента до 
операции перенесли инф аркт мозга, ди агности ­
рованный на КТ, и до операции имели небольшой 
неврологический  деф иц ит. П о к азан и я  к КЭАЭ 
представлены в табл. 1. Сосудисты е ш унты при 
КЭАЭ не использовались. 17 из 24 пациентов при­
нимали аспирин (Lannacher, Австрия) в качестве 
антитромбоцитарного средства, ни один из паци­
ентов не приним ал антиоксидантов.
Содержание TBARS в артериальной 
крови через 5 м и н ут  после п р ек р а ­
щ ения переж атия  со н н о й  ар тер и и  
(1,7 ±0,1 нмоль/л) достоверно повыш а­
лось относительно исходного уровня 
(1,5±0,1 нмоль/л). Одновременно, то 
есть через 5 минут после снятия ка­
ротидного заж им а, наблю далось по­
вышение уровня КАТ и GSHPx (8 9 ± 9  
ед/л и 38 ± 3  ед/г НЬ, соответственно) 
относительно исходных значений. Для 
других маркеров ОС (DC, СОД и ООА) 
не выявлено достоверных изменений 
после проведения КЭАЭ. Аналогично, 
гл у тат ионовы  й о к и с л и т е л ь н о -в о с ­
становительн ы й  статус остался  без 
изменений (табл. 2).
ОБСУЖ ДЕНИ Е 
И зменения уровня маркеров ОС 
в периферической артериальной кро­
ви о тн о си те л ь н о  и сх о дн ы х  зн а ч е ­
ний наблю дал и сь  то л ьк о  в период 
р еп ер ф у зи и  (ч е р е з  5 м и н у т  после  
удален ия за ж и м а), но не во время 
иш ем ии или в более поздн и й  срок 
после в о с с т а н о в л е н и я  к р о в о т о к а  
(через 30 минут). М аркер перекисно- 
го о ки сл ен и я  л и п и до в  — TR A R S 
дем онстрировал самые высокие зн а­
чени я  чер ез 5 м и н у т  после н ачала  
реперфузии. О днако в тот же момент
with the corresponding value at the preclamping time 
point. The other markers as DC, SOD and TAC did not 
show any statistically significant changes during CAE. 
Si multaneously, the glutathione redox ratio did not reveal 
any changes during CAE (Table 2).
DISCUSSION 
We observed changes in different markers of OxS, 
assessed from the peripheral arterial line, only du r­
ing reperfusion (5 min after carotid clamp removal) in 
comparison with preoperative values, but not during 
ischemia or later (at time point 30 min) duri ng reperfu­
sion. A marker of lipid peroxidation, TBA RS, showed the 
highest value 5 min after the beginning of reperfusion. 
At the same time, another more specific marker of lipid 
peroxidation, DC, did not reveal statistically significant 
changes during CAE. Previously, Soong et al. obtained 
sim ilar findings when measuring malondialdehyde and 
diene conjugates at the time point of 1 min after carotid 
clamp removal [14]. However, when comparing the re­
sults of our study with those of the above mentioned study, 
it should be noted that we collected the blood samples
Таблица 2/Table 2
С равнительная  д и н а м и к а  п о казателей  с ис тем н о го
И КЛЕТОЧНОГО ОКИСЛИТЕЛЬНОГО СТРЕССА 
ВО ВРЕМЯ КАРОТИДНОЙ ЭНДАРТЕРЭКТОМИИ 
(п = 17-27)
C om parative  dynamics o f  th e  indices 
o f  system ic and c e l lu la r  OxS d u rin g  CAE 
(n = 17-27)
Время измерения 
Time points during CAE
A В С D
TBARS нмоль/мл 
TBARS, nmol/ml
1.5 ± 0.1 1.6 ± 0.1 1.7 + 0 .Г 1.6±0.1
DC мкмоль/мл 
DC, (i,mol/ml
29.712.1 30.6±2.1 28.5± 1.9 27.9+1.9
OOA, % 
TAC, %
36 ± 1 35± 1 35± 1 35 ± 1
К AT, ед/л 
CAT, U/l
65 ±6 84 ±7 89 ±9* 85±3
СОД, ед/г НЬ 
SOD, U/gHb
674 ±31 686+39 649±43 655±44
GSHPx, ед/гНЬ 
GSHPX, U/gHb
36±3 37 + 3 38±3* 37 ±3
GSSG/GSH
GSSG/GSH
0.9 + 0.17 1.0±0.19 0.9±0.19 1.0 + 0.23
* — p<0,05 для разницы между точками А и С;
А — до введения анестезии;
В — через 5 мин после пережатия сонной артерии;
С — через 5 мин после восстановления кровотока в сонной артерии; 
D — через 30 мин после восстановления кровотока в сонной артерии. 
*р < 0.05 for the differences between the values of time points A and С
A. before induction of anesthesia
B. 5 min after carotid artery clamping
C. 5 min after removal of the carotid artery clamp
D. 30 min after removal of the carotid artery clamp
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к о л еб ан и я  другого , более сп ец и ф и ч н о го  м ар ­
кера перекисного окисления липи дов — DC — 
не были статистически достоверными. Ранее Soong 
étal. [14] получили аналогичные результаты, измерив 
концентрацию малонового диальдегида и диеновых 
коныогатов через 1 минуту после восстановления 
кровотока в сонной артерии. Однако, сравнивая 
наши результаты с данны ми этого исследования, 
следует отметить, что мы отбирали пробы крови из 
периферической артерии, a Soong et al. — из ярем­
ной вены. Другой маркер системного ОС —ООА — 
отраж ает общ ую  антиоксидантную  способность 
плазмы. Согласно данным нашего исследования, 
изменений в ООА при проведении КЭАЭ не было. 
Мы считаем, что иш емия во время КЭАЭ была не­
достаточно тяжелой или продолжительной, чтобы 
истощ ить резерв такой важной защ итной системы, 
как ООА плазмы крови.
Кроме того, чтобы лучше понять степень ОС 
при проведении КЭАЭ, мы измерили динам ику  
значений основны х маркеров внутриклеточного 
ОС. Была обнаруж ена статистически значимое, 
но довольно небольш ое повыш ение активности 
антиоксидантны х ферментов — КАТ и GSHPx — 
через 5 м и н у т  после удален ия заж и м а сонной  
артерии. О днако изм енений  в активности  еще 
одного антиоксидантного фермента — СОД — не 
выявлено. Кроме того, мы обнаружили интерес­
ны й ф акт некоторого повышения ОС в системе, 
контролирующей уровень перекисного окисления 
(например, КАТ и GSHPx), поскольку ф ункция 
GSHPx связана с глутатионовой системой. Более 
того, не выявлено изменений в хорошо известном 
внутриклеточном  маркере ОС — глутатионовом 
окислительно-восстановительном статусе (GSSG/ 
GSH) — этот уровень был одинаково высоким, на­
чиная с первого, предоперационного измерения. В 
наших предшествующих работах мы провели изме­
рение GSSG/GSH у здоровых добровольцев того же 
возраста и вы числили референтный нормальный 
интервал значений этого показателя — от 0,13 до 
0,3. Таким образом, наблюдалась существенная раз­
ница между референтным интервалом и предопе­
рационным уровнем G SSG/GSH, что указывает на 
значительны й внутриклеточны й окислительный 
стресс у наш их пациентов. Возможно, для этой 
категории  пациентов  целесообразно проводить 
коррекцию  активности  глутатионовой системы 
(например, глютамином, 1Ч'-ацетил-Ь-цистеином и 
др.). Хотелось бы также отметить интересный факт, 
который может быть связан с чрезвычайно высоким 
уровнем G SSG /G SH  в нашей группе пациентов. 
У 13 из 24 пациентов диагностирована патология 
периферических артерий. Недавно Lapenna et al. 
[15] п р о д ем о н стр и р о вал и , что д л и тел ьн ая  н е-
from the peripheral arterial line, but Soong et al obtained 
the samples from the jugular vein. Another marker of 
systemic OxS, serum TAC, reflects the potency of total 
antioxidative protection in the plasma. According to the 
findings of our study, there occurred no changes in the 
level ofTAC during CAE. We believe that the episode of 
ischaemia that occurred during CAE was not sufficiently 
severe or long to cause exhaustion o f potency of such an 
important system as total antioxidative capacity in the 
blood plasma.
Furthermore, in order to have a better understand­
ing o f the grade of OxS during CAE, we have also in­
vestigated the m ain markers of intracellular OxS. We 
detected a statistically significant but relatively modest 
increase in the activity o f antioxidative enzymes, CAT 
and GSHPx, 5 min after the removal of the carotid 
artery clamp. However, no changes in the activity of 
the antioxidative enzyme, SOD, during CAE occurred. 
Furtherm ore, we established some elevated OxS in 
peroxide level controlling system (e.g. CAT, GSHPx), 
which is interesting as GSHPx function is associated 
with glutathione system. Moreover, we detected no 
changes in the well-known intracellular marker for OxS, 
the glutathione redox ratio, during this tim e-course 
study, while we observed a high level of the glutathione 
redox ratio at the first tim e point (preoperative value). 
In our previous studies we established the glutathione 
redox ratio from age-matched healthy volunteers and 
calculated the reference value that ranged from 0.13 
to 0.3. We observed a significant difference between 
the reference value and the preoperative value of the 
glutathione redox ratio, which indicates a high level of 
intracellular OxS in these patients. It seems that any 
correction of glutathione system using different ma­
nipulations (e.g. glutam ine, N-A cetyl-L-cystein etc) 
should be considered for these patients. Furthermore, 
we emphasise an interesting fact, which might be cor­
related with the enormously high values o f the gluta­
thione redox ratio in our study group. We established 
concom itant peripheral arterial disease in thirteen 
patients of 24. Recently, Lapenna et al. demonstrated 
that long-term  depletion o f GSH is associated with 
oxidative atherogenic effects [15]. It is evident that 
further investigations should be performed to clarify 
the association of GSH depletion with PAD.
There are several limitations concerning this study. 
It might be a problem to achieve clearly understandable 
results with relevant small number of patients like in our 
study group. However, we believe, that some interesting 
information about the time-course of OxS during CAE is 
possible to denote from our study. Moreover, in our study 
the blood samples were obtained only from peripheral 
artery and therefore we emphasise that, the changes oc­
curred in OxS markers could not beorgan-specifically 
interpreted.
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хватка восстановленной формы глутатиона (GSH) 
связана с атерогенны м окислительным эффектом. 
Очевидно, нужны дополнительные исследования 
для уточнения взаимосвязи между нехваткой GSH 
и болезнью периферических сосудов.
В нашем исследовании было несколько огра­
ничений. Возможно, на таком небольш ом числе 
пациентов, как в данном случае, трудно сделать 
однозначные выводы. Однако нам кажется, что эта 
работа дает некоторую интересную  информацию
о временной динам ике ОС при проведении КЭАЭ. 
Кроме того, в данном случае пробы крови были по­
лучены из периферической артерии. В этой связи 
необходимо подчеркнуть, что изменения в уровне 
маркеров ОС нельзя относить на какой-либо от­
дельный орган.
ВЫВОДЫ
Мы не вы явили интенсивного окислительного 
стресса на системном и клеточном уровнях во время 
проведения каротидной эндартерэктомии. Кроме 
того, пациенты имели высокий предоперационный 
уровень глутатионового окислительно-восстано­
вительного статуса. Последний ф акт заслуживает 
дальнейш его исследования и рассмотрения воз­
можности адью вантной терапии.
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CONCLUSIONS 
We observed no high grade OxS either in systemic or 
cellular level during carotid endarterectomy. Moreover, the 
patients undergoing CAE had a high baseline of the gluta­
thione redox ratio. The latter phenomenon might support 
further investigation and tension of adjuvant therapy.
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